{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/arvidl/ELMED219-2026/blob/main/Lab3-GenAI-LLM/notebooks/08-nevrosymbolsk-ai.ipynb)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Nevrosymbolsk AI - Hybrid intelligens\n",
        "\n",
        "**ELMED219 / BMED365 - Lab 3**\n",
        "\n",
        "---\n",
        "\n",
        "## Læringsmål\n",
        "\n",
        "Etter denne notebooken skal du kunne:\n",
        "- Forklare forskjellen mellom nevrale og symbolske AI-tilnærminger\n",
        "- Beskrive konseptet nevrosymbolsk AI (hybrid AI)\n",
        "- Forstå rollen til kunnskapsgrafer i medisinsk AI\n",
        "- Diskutere hvordan nevrosymbolsk AI kan forbedre forklarbarhet og pålitelighet"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "## Innhold\n",
        "\n",
        "1. [To tradisjoner i AI](#1-to-tradisjoner-i-ai)\n",
        "2. [Nevrosymbolsk integrasjon](#2-nevrosymbolsk-integrasjon)\n",
        "3. [Kunnskapsgrafer](#3-kunnskapsgrafer)\n",
        "4. [Medisinske ontologier](#4-medisinske-ontologier)\n",
        "5. [Anvendelser i medisin](#5-anvendelser-i-medisin)\n",
        "6. [**Case study: Nevrosymbolsk AI for hjernesvulster (Gliom)**](#6-case-study-hjernesvulster)\n",
        "   - [Agentisk AI: Neste steg for klinisk beslutningsstøtte](#agentisk-ai)\n",
        "7. [Fremtidsperspektiver](#7-fremtidsperspektiver)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 1. To tradisjoner i AI\n",
        "\n",
        "Kunstig intelligens har historisk sett utviklet seg langs to hovedlinjer:\n",
        "\n",
        "### Symbolsk AI (\"Good Old-Fashioned AI\")\n",
        "\n",
        "- Eksplisitt representasjon av kunnskap\n",
        "- Logisk resonnering og regler\n",
        "- Tolkbare beslutninger\n",
        "- Eksempler: Ekspertsystemer, beslutningstrær\n",
        "\n",
        "### Nevralt (sub-symbolsk) AI\n",
        "\n",
        "- Lærer mønstre fra data\n",
        "- Implisitt kunnskapsrepresentasjon (vekter)\n",
        "- Ofte \"sort boks\"\n",
        "- Eksempler: Nevrale nettverk, LLM-er"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 14,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "SYMBOLSK vs. NEVRAL AI\n",
            "============================================================\n",
            "\n",
            "Symbolsk AI:\n",
            "----------------------------------------\n",
            "Styrker:\n",
            "  + Tolkbart - vi forstår hvorfor\n",
            "  + Kan inkorporere ekspertkunnskap direkte\n",
            "  + Garanterte egenskaper (bevisbar)\n",
            "  + Fungerer med lite data\n",
            "Svakheter:\n",
            "  - Krever manuell kunnskapsmodellering\n",
            "  - Håndterer ikke usikkerhet godt\n",
            "  - Skalerer dårlig til komplekse problemer\n",
            "  - Brittle - feiler på uventet input\n",
            "\n",
            "Nevral AI:\n",
            "----------------------------------------\n",
            "Styrker:\n",
            "  + Lærer automatisk fra data\n",
            "  + Håndterer komplekse mønstre\n",
            "  + Robust mot støy\n",
            "  + Skalerer til store problemer\n",
            "Svakheter:\n",
            "  - Krever store mengder data\n",
            "  - Vanskelig å tolke (sort boks)\n",
            "  - Kan lære bias fra data\n",
            "  - Mangler garantier\n"
          ]
        }
      ],
      "source": [
        "# Sammenligning av tilnærmingene\n",
        "\n",
        "tilnaerminger = {\n",
        "    \"Symbolsk AI\": {\n",
        "        \"styrker\": [\n",
        "            \"Tolkbart - vi forstår hvorfor\",\n",
        "            \"Kan inkorporere ekspertkunnskap direkte\",\n",
        "            \"Garanterte egenskaper (bevisbar)\",\n",
        "            \"Fungerer med lite data\"\n",
        "        ],\n",
        "        \"svakheter\": [\n",
        "            \"Krever manuell kunnskapsmodellering\",\n",
        "            \"Håndterer ikke usikkerhet godt\",\n",
        "            \"Skalerer dårlig til komplekse problemer\",\n",
        "            \"Brittle - feiler på uventet input\"\n",
        "        ]\n",
        "    },\n",
        "    \"Nevral AI\": {\n",
        "        \"styrker\": [\n",
        "            \"Lærer automatisk fra data\",\n",
        "            \"Håndterer komplekse mønstre\",\n",
        "            \"Robust mot støy\",\n",
        "            \"Skalerer til store problemer\"\n",
        "        ],\n",
        "        \"svakheter\": [\n",
        "            \"Krever store mengder data\",\n",
        "            \"Vanskelig å tolke (sort boks)\",\n",
        "            \"Kan lære bias fra data\",\n",
        "            \"Mangler garantier\"\n",
        "        ]\n",
        "    }\n",
        "}\n",
        "\n",
        "print(\"SYMBOLSK vs. NEVRAL AI\")\n",
        "print(\"=\" * 60)\n",
        "\n",
        "for navn, info in tilnaerminger.items():\n",
        "    print(f\"\\n{navn}:\")\n",
        "    print(\"-\" * 40)\n",
        "    print(\"Styrker:\")\n",
        "    for s in info['styrker']:\n",
        "        print(f\"  + {s}\")\n",
        "    print(\"Svakheter:\")\n",
        "    for s in info['svakheter']:\n",
        "        print(f\"  - {s}\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 2. Nevrosymbolsk integrasjon\n",
        "\n",
        "**Nevrosymbolsk AI** kombinerer det beste fra begge verdener:\n",
        "\n",
        "```\n",
        "┌─────────────────────────────────────────────────────────────┐\n",
        "│                    NEVROSYMBOLSK AI                         │\n",
        "├─────────────────────────────────────────────────────────────┤\n",
        "│                                                             │\n",
        "│   Symbolsk lag                    Nevralt lag               │\n",
        "│   ┌───────────┐                   ┌───────────┐             │\n",
        "│   │ Kunnskap  │ ←──────────────→  │  Mønstre  │             │\n",
        "│   │ Regler    │    Integrasjon    │  Data     │             │\n",
        "│   │ Ontologi  │                   │  Læring   │             │\n",
        "│   └───────────┘                   └───────────┘             │\n",
        "│        ↓                               ↓                    │\n",
        "│   Forklaring                     Fleksibilitet              │\n",
        "│   Garantier                      Robusthet                  │\n",
        "│                                                             │\n",
        "└─────────────────────────────────────────────────────────────┘\n",
        "```\n",
        "\n",
        "### Integrasjonsstrategier\n",
        "\n",
        "1. **Symbolsk→Nevral**: Bruk kunnskapsgraf til å forbedre nettverkstrening\n",
        "2. **Nevral→Symbolsk**: Ekstrahér symbolsk kunnskap fra lærte modeller\n",
        "3. **Hybrid resonnering**: Kombiner logisk og probabilistisk inferens"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 3. Kunnskapsgrafer\n",
        "\n",
        "En **kunnskapsgraf** representerer kunnskap som et nettverk av entiteter (noder) og relasjoner (kanter).\n",
        "\n",
        "### Struktur\n",
        "\n",
        "```\n",
        "(Entitet) --[relasjon]--> (Entitet)\n",
        "\n",
        "Eksempel:\n",
        "(Diabetes) --[behandles_med]--> (Metformin)\n",
        "(Metformin) --[er_en]--> (Antidiabetikum)\n",
        "(Diabetes) --[har_symptom]--> (Polyuri)\n",
        "```"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 15,
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 1200x800 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "\n",
        "# Enkel kunnskapsgraf-visualisering\n",
        "\n",
        "def tegn_medisinsk_kunnskapsgraf():\n",
        "    \"\"\"\n",
        "    Tegner en enkel medisinsk kunnskapsgraf.\n",
        "    \"\"\"\n",
        "    fig, ax = plt.subplots(figsize=(12, 8))\n",
        "    \n",
        "    # Definer noder (entiteter)\n",
        "    noder = {\n",
        "        'Diabetes T2': (0.5, 0.8),\n",
        "        'Metformin': (0.2, 0.5),\n",
        "        'Insulin': (0.4, 0.3),\n",
        "        'Hyperglykemi': (0.8, 0.7),\n",
        "        'Polyuri': (0.9, 0.5),\n",
        "        'HbA1c': (0.6, 0.5),\n",
        "        'Overvekt': (0.3, 0.8),\n",
        "        'Hjertesykdom': (0.7, 0.2)\n",
        "    }\n",
        "    \n",
        "    # Definer kanter (relasjoner)\n",
        "    kanter = [\n",
        "        ('Diabetes T2', 'Metformin', 'behandles_med'),\n",
        "        ('Diabetes T2', 'Insulin', 'behandles_med'),\n",
        "        ('Diabetes T2', 'Hyperglykemi', 'forårsaker'),\n",
        "        ('Hyperglykemi', 'Polyuri', 'gir_symptom'),\n",
        "        ('Diabetes T2', 'HbA1c', 'måles_med'),\n",
        "        ('Overvekt', 'Diabetes T2', 'risikofaktor_for'),\n",
        "        ('Diabetes T2', 'Hjertesykdom', 'øker_risiko_for')\n",
        "    ]\n",
        "    \n",
        "    # Tegn noder\n",
        "    for navn, (x, y) in noder.items():\n",
        "        ax.scatter(x, y, s=2000, c='lightblue', edgecolors='steelblue', linewidths=2, zorder=3)\n",
        "        ax.annotate(navn, (x, y), ha='center', va='center', fontsize=9, fontweight='bold')\n",
        "    \n",
        "    # Tegn kanter\n",
        "    for fra, til, relasjon in kanter:\n",
        "        x1, y1 = noder[fra]\n",
        "        x2, y2 = noder[til]\n",
        "        \n",
        "        # Tegn pil\n",
        "        ax.annotate('', xy=(x2, y2), xytext=(x1, y1),\n",
        "                    arrowprops=dict(arrowstyle='->', color='gray', lw=1.5),\n",
        "                    zorder=1)\n",
        "        \n",
        "        # Legg til relasjonsnavn\n",
        "        midx, midy = (x1 + x2) / 2, (y1 + y2) / 2\n",
        "        ax.annotate(relasjon, (midx, midy), fontsize=7, color='darkred',\n",
        "                    ha='center', va='bottom', style='italic')\n",
        "    \n",
        "    ax.set_xlim(0, 1)\n",
        "    ax.set_ylim(0, 1)\n",
        "    ax.set_aspect('equal')\n",
        "    ax.axis('off')\n",
        "    ax.set_title('Medisinsk kunnskapsgraf: Diabetes og relaterte konsepter', fontsize=12, pad=20)\n",
        "    \n",
        "    plt.tight_layout()\n",
        "    plt.show()\n",
        "\n",
        "tegn_medisinsk_kunnskapsgraf()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 4. Medisinske ontologier\n",
        "\n",
        "Medisinen har utviklet omfattende ontologier - strukturerte vokabularer med definerte begreper og relasjoner.\n",
        "\n",
        "### Viktige medisinske ontologier\n",
        "\n",
        "| Ontologi | Beskrivelse | Bruksområde |\n",
        "|----------|-------------|-------------|\n",
        "| **SNOMED CT** | Comprehensive clinical terminology | Klinisk dokumentasjon |\n",
        "| **ICD-10/11** | International Classification of Diseases | Diagnosekoding |\n",
        "| **LOINC** | Logical Observation Identifiers | Laboratorietester |\n",
        "| **RxNorm** | Normalized drug names | Legemidler |\n",
        "| **HPO** | Human Phenotype Ontology | Genetikk/fenotyper |\n",
        "\n",
        "### Hvordan ontologier styrker AI\n",
        "\n",
        "1. **Standardisering**: Felles språk på tvers av systemer\n",
        "2. **Resonnering**: Utlede ny kunnskap fra relasjoner\n",
        "3. **Validering**: Sjekke konsistens i data\n",
        "4. **Forklaring**: Gi meningsfulle forklaringer"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 16,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "ONTOLOGI-BASERT RESONNERING\n",
            "==================================================\n",
            "\n",
            "Spørsmål: Behandler Metformin diabetes?\n",
            "\n",
            "Resonnering:\n",
            "  1. Metformin IS_A Antidiabetikum\n",
            "  2. Antidiabetikum TREATS Diabetes\n",
            "  → Konklusjon: JA, Metformin behandler Diabetes\n",
            "\n",
            "--------------------------------------------------\n",
            "\n",
            "Spørsmål: Kan pasient med nyresvikt bruke Metformin?\n",
            "\n",
            "Resonnering:\n",
            "  1. Metformin CONTRAINDICATED Nyresvikt\n",
            "  → Konklusjon: NEI, kontraindisert ved nyresvikt\n",
            "  → VARSEL: Vurder alternativ (f.eks. Insulin)\n"
          ]
        }
      ],
      "source": [
        "# Eksempel på ontologi-basert resonnering\n",
        "\n",
        "def ontologi_resonnering():\n",
        "    \"\"\"\n",
        "    Demonstrerer hvordan ontologi-kunnskap kan forbedre AI-resonnering.\n",
        "    \"\"\"\n",
        "    # Simulert kunnskapsbase\n",
        "    ontologi = {\n",
        "        \"is_a\": {\n",
        "            \"Metformin\": \"Antidiabetikum\",\n",
        "            \"Antidiabetikum\": \"Legemiddel\",\n",
        "            \"Insulin\": \"Antidiabetikum\"\n",
        "        },\n",
        "        \"treats\": {\n",
        "            \"Antidiabetikum\": \"Diabetes\"\n",
        "        },\n",
        "        \"contraindicated\": {\n",
        "            \"Metformin\": \"Nyresvikt\"\n",
        "        }\n",
        "    }\n",
        "    \n",
        "    print(\"ONTOLOGI-BASERT RESONNERING\")\n",
        "    print(\"=\" * 50)\n",
        "    \n",
        "    # Resonnering: \"Behandler Metformin diabetes?\"\n",
        "    print(\"\\nSpørsmål: Behandler Metformin diabetes?\")\n",
        "    print(\"\\nResonnering:\")\n",
        "    print(\"  1. Metformin IS_A Antidiabetikum\")\n",
        "    print(\"  2. Antidiabetikum TREATS Diabetes\")\n",
        "    print(\"  → Konklusjon: JA, Metformin behandler Diabetes\")\n",
        "    \n",
        "    print(\"\\n\" + \"-\"*50)\n",
        "    \n",
        "    # Resonnering med kontraindikasjon\n",
        "    print(\"\\nSpørsmål: Kan pasient med nyresvikt bruke Metformin?\")\n",
        "    print(\"\\nResonnering:\")\n",
        "    print(\"  1. Metformin CONTRAINDICATED Nyresvikt\")\n",
        "    print(\"  → Konklusjon: NEI, kontraindisert ved nyresvikt\")\n",
        "    print(\"  → VARSEL: Vurder alternativ (f.eks. Insulin)\")\n",
        "\n",
        "ontologi_resonnering()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 5. Anvendelser i medisin\n",
        "\n",
        "### Eksempler på nevrosymbolsk AI i helse\n",
        "\n",
        "**1. Diagnose-støtte med forklaring**\n",
        "- Nevralt: Klassifiserer symptomer\n",
        "- Symbolsk: Forklarer via medisinsk ontologi\n",
        "\n",
        "**2. Legemiddelinteraksjoner**\n",
        "- Nevralt: Predikerer interaksjonsrisiko\n",
        "- Symbolsk: Verifiserer mot farmakologisk kunnskap\n",
        "\n",
        "**3. Klinisk beslutningsstøtte**\n",
        "- Nevralt: Risikostratifisering fra data\n",
        "- Symbolsk: Sjekker mot kliniske retningslinjer\n",
        "\n",
        "**4. Biobank-analyse**\n",
        "- Nevralt: Finner mønstre i genomdata\n",
        "- Symbolsk: Kobler til fenotype-ontologi"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "HYBRID DIAGNOSE-SYSTEM\n",
            "============================================================\n",
            "Input symptomer: ['polyuri', 'vekttap', 'økt tørste']\n",
            "\n",
            "STEG 1: Nevral analyse\n",
            "----------------------------------------\n",
            "  Diabetes mellitus: 75%\n",
            "  Hyperthyreose: 15%\n",
            "  Nyresykdom: 10%\n",
            "\n",
            "STEG 2: Symbolsk validering (ontologi-sjekk)\n",
            "----------------------------------------\n",
            "  Sjekker: 'Polyuri' er kjent symptom på 'Diabetes'? ✓\n",
            "  Sjekker: 'Vekttap' er kjent symptom på 'Diabetes'? ✓\n",
            "  Sjekker: 'Tørste' er kjent symptom på 'Diabetes'? ✓\n",
            "  → Alle symptomer er ontologisk konsistente med Diabetes\n",
            "\n",
            "STEG 3: Forklaring til kliniker\n",
            "----------------------------------------\n",
            "  ANBEFALING: Vurder Diabetes mellitus (75% sannsynlighet)\n",
            "  \n",
            "  BEGRUNNELSE:\n",
            "  - Nevral modell identifiserte mønster konsistent med diabetes\n",
            "  - Symptomene (polyuri, vekttap, tørste) er alle klassiske\n",
            "    diabetes-symptomer ifølge SNOMED CT\n",
            "  \n",
            "  ANBEFALT UTREDNING:\n",
            "  - Fastende blodglukose\n",
            "  - HbA1c\n",
            "  \n"
          ]
        }
      ],
      "source": [
        "# Eksempel: Hybrid diagnose-system\n",
        "\n",
        "def hybrid_diagnose_system(symptomer):\n",
        "    \"\"\"\n",
        "    Simulerer et nevrosymbolsk diagnosesystem.\n",
        "    \"\"\"\n",
        "    print(\"HYBRID DIAGNOSE-SYSTEM\")\n",
        "    print(\"=\" * 60)\n",
        "    print(f\"Input symptomer: {symptomer}\")\n",
        "    print()\n",
        "    \n",
        "    # Steg 1: Nevral komponent (simulert)\n",
        "    print(\"STEG 1: Nevral analyse\")\n",
        "    print(\"-\" * 40)\n",
        "    nevral_prediksjoner = {\n",
        "        \"Diabetes mellitus\": 0.75,\n",
        "        \"Hyperthyreose\": 0.15,\n",
        "        \"Nyresykdom\": 0.10\n",
        "    }\n",
        "    for diag, prob in nevral_prediksjoner.items():\n",
        "        print(f\"  {diag}: {prob:.0%}\")\n",
        "    \n",
        "    print()\n",
        "    \n",
        "    # Steg 2: Symbolsk validering\n",
        "    print(\"STEG 2: Symbolsk validering (ontologi-sjekk)\")\n",
        "    print(\"-\" * 40)\n",
        "    print(\"  Sjekker: 'Polyuri' er kjent symptom på 'Diabetes'? ✓\")\n",
        "    print(\"  Sjekker: 'Vekttap' er kjent symptom på 'Diabetes'? ✓\")\n",
        "    print(\"  Sjekker: 'Tørste' er kjent symptom på 'Diabetes'? ✓\")\n",
        "    print(\"  → Alle symptomer er ontologisk konsistente med Diabetes\")\n",
        "    \n",
        "    print()\n",
        "    \n",
        "    # Steg 3: Kombinert output\n",
        "    print(\"STEG 3: Forklaring til kliniker\")\n",
        "    print(\"-\" * 40)\n",
        "    print(\"\"\"  ANBEFALING: Vurder Diabetes mellitus (75% sannsynlighet)\n",
        "  \n",
        "  BEGRUNNELSE:\n",
        "  - Nevral modell identifiserte mønster konsistent med diabetes\n",
        "  - Symptomene (polyuri, vekttap, tørste) er alle klassiske\n",
        "    diabetes-symptomer ifølge SNOMED CT\n",
        "  \n",
        "  ANBEFALT UTREDNING:\n",
        "  - Fastende blodglukose\n",
        "  - HbA1c\n",
        "  \"\"\")\n",
        "\n",
        "# Test\n",
        "hybrid_diagnose_system([\"polyuri\", \"vekttap\", \"økt tørste\"])"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 6. Case study: Nevrosymbolsk AI for hjernesvulster (Gliom) <a id=\"6-case-study-hjernesvulster\"></a>\n",
        "\n",
        "### Motivasjon\n",
        "\n",
        "Hjernesvulster, spesielt **gliomer**, representerer et ideelt anvendelsesområde for nevrosymbolsk AI:\n",
        "\n",
        "1. **Kompleks klassifikasjon**: WHO-klassifikasjonen av CNS-svulster (2021) kombinerer histologiske og molekylære kriterier i et hierarkisk system\n",
        "2. **Rik domenekunskap**: Omfattende ontologier og kunnskapsgrafer eksisterer for nevro-onkologi\n",
        "3. **Kritiske beslutninger**: Behandlingsvalg krever pålitelig, forklarbar AI\n",
        "4. **Multimodale data**: Bildediagnostikk (MRI), genetikk, histopatologi og klinikk må integreres\n",
        "\n",
        "### WHO 2021 CNS Tumor Classification\n",
        "\n",
        "Den nye WHO-klassifikasjonen representerer et paradigmeskifte der **molekylære markører** er integrert i diagnosen:\n",
        "\n",
        "| Tumortype | Nøkkelmarkører | Betydning |\n",
        "|-----------|----------------|-----------|\n",
        "| **Glioblastom, IDH-villtype** | IDH-villtype, +7/-10, TERT | Mest aggressiv, grad 4 |\n",
        "| **Astrocytom, IDH-mutert** | IDH-mutert, ATRX-tap | Grad 2-4 |\n",
        "| **Oligodendrogliom, IDH-mutert** | IDH-mutert, 1p/19q ko-deletert | Bedre prognose |\n",
        "| **Diffust midtlinje-gliom** | H3 K27M-mutert | Barn, dårlig prognose |\n",
        "\n",
        "### Datasett: BraTS Challenge\n",
        "\n",
        "[Brain Tumor Segmentation (BraTS) Challenge](https://www.synapse.org/brats) er en årlig konkurranse som tilbyr:\n",
        "- **Multiparametrisk MRI** (T1, T1Gd, T2, FLAIR)\n",
        "- **Segmenteringsmasker** (enhancing tumor, edema, nekrose)\n",
        "- **Kliniske data** og overlevelsestider\n",
        "\n",
        "I denne casestudien demonstrerer vi hvordan nevrosymbolsk AI kan:\n",
        "1. Bygge en **kunnskapsgraf** for gliom-klassifikasjon\n",
        "2. Kombinere **nevrale prediksjoner** fra bildeanalyse med **symbolsk resonnering**\n",
        "3. Gi **forklarbare** og **verifiserbare** behandlingsanbefalinger"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 18,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✓ Ontologi og dataklasser for gliom er definert\n",
            "  - WHOGrade: ['GRAD_1', 'GRAD_2', 'GRAD_3', 'GRAD_4']\n",
            "  - IDHStatus: ['IDH-villtype', 'IDH-mutert', 'IDH-ukjent']\n",
            "  - MGMTStatus: ['MGMT-metylert', 'MGMT-umetylert', 'MGMT-ukjent']\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# NEVROSYMBOLSK AI FOR GLIOM: Komplett implementasjon\n",
        "# ============================================================================\n",
        "\n",
        "import numpy as np\n",
        "import pandas as pd\n",
        "from dataclasses import dataclass, field\n",
        "from typing import Dict, List, Optional, Tuple, Set\n",
        "from enum import Enum\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "# ============================================================================\n",
        "# DEL 1: ONTOLOGI OG KUNNSKAPSGRAF FOR GLIOM\n",
        "# ============================================================================\n",
        "\n",
        "class WHOGrade(Enum):\n",
        "    \"\"\"WHO-gradering av CNS-tumorer\"\"\"\n",
        "    GRAD_1 = 1\n",
        "    GRAD_2 = 2\n",
        "    GRAD_3 = 3\n",
        "    GRAD_4 = 4\n",
        "\n",
        "class IDHStatus(Enum):\n",
        "    \"\"\"IDH-mutasjonsstatus\"\"\"\n",
        "    VILLTYPE = \"IDH-villtype\"\n",
        "    MUTERT = \"IDH-mutert\"\n",
        "    UKJENT = \"IDH-ukjent\"\n",
        "\n",
        "class MGMTStatus(Enum):\n",
        "    \"\"\"MGMT promoter-metyleringsstatus\"\"\"\n",
        "    METYLERT = \"MGMT-metylert\"\n",
        "    UMETYLERT = \"MGMT-umetylert\"\n",
        "    UKJENT = \"MGMT-ukjent\"\n",
        "\n",
        "@dataclass\n",
        "class MolekylærProfil:\n",
        "    \"\"\"Molekylære markører for gliom\"\"\"\n",
        "    idh_status: IDHStatus\n",
        "    mgmt_status: MGMTStatus\n",
        "    kodeletion_1p19q: bool = False\n",
        "    atrx_tap: bool = False\n",
        "    tert_promoter: bool = False\n",
        "    egfr_amplifisering: bool = False\n",
        "    kromosom_7_gain: bool = False\n",
        "    kromosom_10_loss: bool = False\n",
        "    h3_k27m: bool = False\n",
        "    \n",
        "    def has_glioblastom_profil(self) -> bool:\n",
        "        \"\"\"Sjekk om profilen matcher glioblastom-kriterier\"\"\"\n",
        "        return (self.idh_status == IDHStatus.VILLTYPE and\n",
        "                (self.tert_promoter or self.egfr_amplifisering or\n",
        "                 (self.kromosom_7_gain and self.kromosom_10_loss)))\n",
        "\n",
        "@dataclass\n",
        "class MRIFeatures:\n",
        "    \"\"\"Kvantitative MRI-features fra bildeanalyse\"\"\"\n",
        "    tumor_volum_ml: float\n",
        "    enhancing_volum_ml: float\n",
        "    nekrose_volum_ml: float\n",
        "    ødem_volum_ml: float\n",
        "    enhancing_ratio: float = 0.0\n",
        "    lokalisasjon: str = \"ukjent\"\n",
        "    krysser_midtlinjen: bool = False\n",
        "    involverer_eloquent: bool = False\n",
        "    \n",
        "    def __post_init__(self):\n",
        "        if self.tumor_volum_ml > 0:\n",
        "            self.enhancing_ratio = self.enhancing_volum_ml / self.tumor_volum_ml\n",
        "\n",
        "@dataclass\n",
        "class KliniskProfil:\n",
        "    \"\"\"Kliniske data for pasienten\"\"\"\n",
        "    alder: int\n",
        "    karnofsky_score: int  # 0-100\n",
        "    symptom_varighet_uker: int\n",
        "    reseksjonsstatus: str = \"ukjent\"  # GTR, STR, biopsi\n",
        "    tidligere_behandling: List[str] = field(default_factory=list)\n",
        "\n",
        "@dataclass\n",
        "class GliomPasient:\n",
        "    \"\"\"Komplett pasientprofil for gliom\"\"\"\n",
        "    pasient_id: str\n",
        "    molekylær: MolekylærProfil\n",
        "    mri: MRIFeatures\n",
        "    klinisk: KliniskProfil\n",
        "    histologi: str = \"ukjent\"\n",
        "\n",
        "print(\"✓ Ontologi og dataklasser for gliom er definert\")\n",
        "print(f\"  - WHOGrade: {[g.name for g in WHOGrade]}\")\n",
        "print(f\"  - IDHStatus: {[s.value for s in IDHStatus]}\")\n",
        "print(f\"  - MGMTStatus: {[s.value for s in MGMTStatus]}\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 19,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✓ Gliom-kunnskapsgraf initialisert\n",
            "  - 7 tumortyper definert\n",
            "  - 4 klassifikasjonsregler\n",
            "  - Behandlingsregler for 4 tumortyper\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DEL 2: KUNNSKAPSGRAF FOR GLIOM (Symbolsk komponent)\n",
        "# ============================================================================\n",
        "\n",
        "class GliomKunnskapsgraf:\n",
        "    \"\"\"\n",
        "    Kunnskapsgraf som representerer WHO 2021 CNS-klassifikasjon.\n",
        "    Dette er den SYMBOLSKE komponenten i vårt nevrosymbolske system.\n",
        "    \"\"\"\n",
        "    \n",
        "    def __init__(self):\n",
        "        # Entiteter (noder)\n",
        "        self.tumor_typer = {\n",
        "            \"glioblastom\": {\n",
        "                \"navn\": \"Glioblastom, IDH-villtype\",\n",
        "                \"grad\": WHOGrade.GRAD_4,\n",
        "                \"median_overlevelse_måneder\": 15,\n",
        "                \"beskrivelse\": \"Mest aggressiv primær hjernesvulst hos voksne\"\n",
        "            },\n",
        "            \"astrocytom_2\": {\n",
        "                \"navn\": \"Astrocytom, IDH-mutert, grad 2\",\n",
        "                \"grad\": WHOGrade.GRAD_2,\n",
        "                \"median_overlevelse_måneder\": 96,\n",
        "                \"beskrivelse\": \"Diffust infiltrerende astrocytom med relativt god prognose\"\n",
        "            },\n",
        "            \"astrocytom_3\": {\n",
        "                \"navn\": \"Astrocytom, IDH-mutert, grad 3\",\n",
        "                \"grad\": WHOGrade.GRAD_3,\n",
        "                \"median_overlevelse_måneder\": 60,\n",
        "                \"beskrivelse\": \"Anaplastisk astrocytom med økt mitotisk aktivitet\"\n",
        "            },\n",
        "            \"astrocytom_4\": {\n",
        "                \"navn\": \"Astrocytom, IDH-mutert, grad 4\",\n",
        "                \"grad\": WHOGrade.GRAD_4,\n",
        "                \"median_overlevelse_måneder\": 36,\n",
        "                \"beskrivelse\": \"Høygradig IDH-mutert astrocytom med nekrose/mikrovaskulær proliferasjon\"\n",
        "            },\n",
        "            \"oligodendrogliom_2\": {\n",
        "                \"navn\": \"Oligodendrogliom, IDH-mutert, 1p/19q ko-deletert, grad 2\",\n",
        "                \"grad\": WHOGrade.GRAD_2,\n",
        "                \"median_overlevelse_måneder\": 156,\n",
        "                \"beskrivelse\": \"Godt differensiert oligodendrogliom med gunstig prognose\"\n",
        "            },\n",
        "            \"oligodendrogliom_3\": {\n",
        "                \"navn\": \"Oligodendrogliom, IDH-mutert, 1p/19q ko-deletert, grad 3\",\n",
        "                \"grad\": WHOGrade.GRAD_3,\n",
        "                \"median_overlevelse_måneder\": 114,\n",
        "                \"beskrivelse\": \"Anaplastisk oligodendrogliom\"\n",
        "            },\n",
        "            \"dmg\": {\n",
        "                \"navn\": \"Diffust midtlinje-gliom, H3 K27M-mutert\",\n",
        "                \"grad\": WHOGrade.GRAD_4,\n",
        "                \"median_overlevelse_måneder\": 11,\n",
        "                \"beskrivelse\": \"Aggressiv pediatrisk tumor i hjernestamme/thalamus\"\n",
        "            }\n",
        "        }\n",
        "        \n",
        "        # Relasjoner (kanter)\n",
        "        self.klassifikasjonsregler = self._bygg_klassifikasjonsregler()\n",
        "        self.behandlingsregler = self._bygg_behandlingsregler()\n",
        "        self.prognostiske_faktorer = self._bygg_prognostiske_faktorer()\n",
        "    \n",
        "    def _bygg_klassifikasjonsregler(self) -> Dict:\n",
        "        \"\"\"WHO 2021 klassifikasjonsregler som logiske betingelser\"\"\"\n",
        "        return {\n",
        "            \"glioblastom\": {\n",
        "                \"krav\": [\n",
        "                    (\"idh_status\", \"==\", IDHStatus.VILLTYPE),\n",
        "                    (\"histologi\", \"in\", [\"glioblastom\", \"høygradig_gliom\"]),\n",
        "                ],\n",
        "                \"eller_molekylært\": [\n",
        "                    (\"tert_promoter\", \"==\", True),\n",
        "                    (\"egfr_amplifisering\", \"==\", True),\n",
        "                    ((\"kromosom_7_gain\", \"==\", True), (\"kromosom_10_loss\", \"==\", True))\n",
        "                ]\n",
        "            },\n",
        "            \"oligodendrogliom\": {\n",
        "                \"krav\": [\n",
        "                    (\"idh_status\", \"==\", IDHStatus.MUTERT),\n",
        "                    (\"kodeletion_1p19q\", \"==\", True)\n",
        "                ]\n",
        "            },\n",
        "            \"astrocytom_idh_mutert\": {\n",
        "                \"krav\": [\n",
        "                    (\"idh_status\", \"==\", IDHStatus.MUTERT),\n",
        "                    (\"kodeletion_1p19q\", \"==\", False),\n",
        "                    (\"atrx_tap\", \"==\", True)\n",
        "                ]\n",
        "            },\n",
        "            \"dmg\": {\n",
        "                \"krav\": [\n",
        "                    (\"h3_k27m\", \"==\", True),\n",
        "                    (\"lokalisasjon\", \"in\", [\"pons\", \"thalamus\", \"midtlinje\"])\n",
        "                ]\n",
        "            }\n",
        "        }\n",
        "    \n",
        "    def _bygg_behandlingsregler(self) -> Dict:\n",
        "        \"\"\"Behandlingsanbefalinger basert på tumor-type og molekylær profil\"\"\"\n",
        "        return {\n",
        "            \"glioblastom\": {\n",
        "                \"standard\": [\"Maksimal sikker reseksjon\", \"Temozolomid + stråling (Stupp-protokoll)\"],\n",
        "                \"mgmt_metylert\": [\"Temozolomid har økt effekt\", \"Tumor Treating Fields (TTFields) vurderes\"],\n",
        "                \"mgmt_umetylert\": [\"Vurder alternativ til temozolomid\", \"Kliniske studier anbefales\"],\n",
        "                \"eldre_pasient\": [\"Hypofraksjonert stråling\", \"Temozolomid monoterapi hvis MGMT-metylert\"]\n",
        "            },\n",
        "            \"astrocytom_idh_mutert\": {\n",
        "                \"grad_2\": [\"Observasjon vs. tidlig behandling\", \"Reseksjon ved progresjon\"],\n",
        "                \"grad_3_4\": [\"Reseksjon + stråling + kjemoterapi\", \"PCV eller temozolomid\"],\n",
        "                \"vorasidenib\": [\"IDH-hemmer (godkjent 2024) for lavgradige\"]\n",
        "            },\n",
        "            \"oligodendrogliom\": {\n",
        "                \"grad_2\": [\"Maksimal sikker reseksjon\", \"Stråling + PCV ved høy risiko\"],\n",
        "                \"grad_3\": [\"Reseksjon + stråling + PCV\", \"Temozolomid som alternativ\"]\n",
        "            },\n",
        "            \"dmg\": {\n",
        "                \"standard\": [\"Stråling (palliativ)\", \"Ingen standard kjemoterapi effektiv\"],\n",
        "                \"kliniske_studier\": [\"ONC201\", \"CAR-T-terapi\"]\n",
        "            }\n",
        "        }\n",
        "    \n",
        "    def _bygg_prognostiske_faktorer(self) -> Dict:\n",
        "        \"\"\"Prognostiske faktorer med evidensgrad\"\"\"\n",
        "        return {\n",
        "            \"positiv\": [\n",
        "                (\"IDH-mutasjon\", \"sterk\", \"Betydelig bedre prognose\"),\n",
        "                (\"1p/19q ko-delesjon\", \"sterk\", \"Bedre respons på kjemoterapi\"),\n",
        "                (\"MGMT-metylering\", \"sterk\", \"Bedre respons på temozolomid\"),\n",
        "                (\"Ung alder (<40)\", \"moderat\", \"Bedre toleranse for behandling\"),\n",
        "                (\"Høy Karnofsky (>70)\", \"sterk\", \"Bedre funksjonsstatus\"),\n",
        "                (\"Gross total resection\", \"sterk\", \"Økt progresjonsfri overlevelse\")\n",
        "            ],\n",
        "            \"negativ\": [\n",
        "                (\"IDH-villtype\", \"sterk\", \"Kortere overlevelse\"),\n",
        "                (\"TERT-promoter mutasjon\", \"moderat\", \"Aggressiv biologi\"),\n",
        "                (\"EGFR-amplifisering\", \"moderat\", \"Glioblastom-assosiert\"),\n",
        "                (\"Alder >65\", \"moderat\", \"Redusert behandlingstoleranse\"),\n",
        "                (\"Lav Karnofsky (<70)\", \"sterk\", \"Dårligere utfall\"),\n",
        "                (\"Multifokal tumor\", \"moderat\", \"Ikke kandidat for reseksjon\")\n",
        "            ]\n",
        "        }\n",
        "    \n",
        "    def klassifiser_tumor(self, pasient: GliomPasient) -> Tuple[str, Dict]:\n",
        "        \"\"\"\n",
        "        Klassifiser tumor basert på WHO 2021-kriterier.\n",
        "        Returnerer tuple av (tumor_type, forklaring_dict)\n",
        "        \"\"\"\n",
        "        mol = pasient.molekylær\n",
        "        forklaring = {\"anvendte_regler\": [], \"konklusjon\": \"\", \"usikkerhet\": []}\n",
        "        \n",
        "        # Sjekk H3 K27M først (har høy prioritet)\n",
        "        if mol.h3_k27m:\n",
        "            forklaring[\"anvendte_regler\"].append(\"H3 K27M-mutasjon påvist → Diffust midtlinje-gliom\")\n",
        "            return \"dmg\", forklaring\n",
        "        \n",
        "        # Sjekk IDH-status\n",
        "        if mol.idh_status == IDHStatus.VILLTYPE:\n",
        "            forklaring[\"anvendte_regler\"].append(\"IDH-villtype påvist\")\n",
        "            \n",
        "            # Sjekk for glioblastom-kriterier\n",
        "            gbm_kriterier = []\n",
        "            if mol.tert_promoter:\n",
        "                gbm_kriterier.append(\"TERT-promoter mutasjon\")\n",
        "            if mol.egfr_amplifisering:\n",
        "                gbm_kriterier.append(\"EGFR-amplifisering\")\n",
        "            if mol.kromosom_7_gain and mol.kromosom_10_loss:\n",
        "                gbm_kriterier.append(\"+7/-10 kromosomendringer\")\n",
        "            \n",
        "            if gbm_kriterier:\n",
        "                forklaring[\"anvendte_regler\"].append(f\"Glioblastom-markører: {', '.join(gbm_kriterier)}\")\n",
        "                forklaring[\"konklusjon\"] = \"Glioblastom, IDH-villtype, grad 4\"\n",
        "                return \"glioblastom\", forklaring\n",
        "            else:\n",
        "                forklaring[\"usikkerhet\"].append(\"Ingen spesifikke GBM-markører, men IDH-villtype\")\n",
        "                forklaring[\"konklusjon\"] = \"Sannsynlig glioblastom (krever histologi)\"\n",
        "                return \"glioblastom\", forklaring\n",
        "        \n",
        "        elif mol.idh_status == IDHStatus.MUTERT:\n",
        "            forklaring[\"anvendte_regler\"].append(\"IDH-mutasjon påvist\")\n",
        "            \n",
        "            # Sjekk for oligodendrogliom\n",
        "            if mol.kodeletion_1p19q:\n",
        "                forklaring[\"anvendte_regler\"].append(\"1p/19q ko-delesjon påvist → Oligodendrogliom\")\n",
        "                # Gradering basert på histologi/MRI\n",
        "                if pasient.mri.nekrose_volum_ml > 0 or pasient.mri.enhancing_ratio > 0.3:\n",
        "                    forklaring[\"konklusjon\"] = \"Oligodendrogliom, grad 3\"\n",
        "                    return \"oligodendrogliom_3\", forklaring\n",
        "                else:\n",
        "                    forklaring[\"konklusjon\"] = \"Oligodendrogliom, grad 2\"\n",
        "                    return \"oligodendrogliom_2\", forklaring\n",
        "            \n",
        "            # Astrocytom\n",
        "            else:\n",
        "                forklaring[\"anvendte_regler\"].append(\"Ingen 1p/19q ko-delesjon → Astrocytom\")\n",
        "                if mol.atrx_tap:\n",
        "                    forklaring[\"anvendte_regler\"].append(\"ATRX-tap bekrefter astrocytom-linje\")\n",
        "                \n",
        "                # Gradering\n",
        "                if pasient.mri.nekrose_volum_ml > 0:\n",
        "                    forklaring[\"konklusjon\"] = \"Astrocytom, IDH-mutert, grad 4\"\n",
        "                    return \"astrocytom_4\", forklaring\n",
        "                elif pasient.mri.enhancing_ratio > 0.3:\n",
        "                    forklaring[\"konklusjon\"] = \"Astrocytom, IDH-mutert, grad 3\"\n",
        "                    return \"astrocytom_3\", forklaring\n",
        "                else:\n",
        "                    forklaring[\"konklusjon\"] = \"Astrocytom, IDH-mutert, grad 2\"\n",
        "                    return \"astrocytom_2\", forklaring\n",
        "        \n",
        "        # Ukjent IDH\n",
        "        forklaring[\"usikkerhet\"].append(\"IDH-status ukjent - klassifikasjon usikker\")\n",
        "        return \"ukjent\", forklaring\n",
        "    \n",
        "    def generer_behandlingsanbefaling(self, pasient: GliomPasient, \n",
        "                                       tumor_type: str) -> Dict:\n",
        "        \"\"\"\n",
        "        Generer behandlingsanbefaling basert på symbolsk resonnering.\n",
        "        \"\"\"\n",
        "        anbefaling = {\n",
        "            \"primær_behandling\": [],\n",
        "            \"tilleggsbehandling\": [],\n",
        "            \"prognostiske_kommentarer\": [],\n",
        "            \"anbefalte_studier\": []\n",
        "        }\n",
        "        \n",
        "        regler = self.behandlingsregler.get(tumor_type, {})\n",
        "        \n",
        "        # Standard behandling\n",
        "        if \"standard\" in regler:\n",
        "            anbefaling[\"primær_behandling\"].extend(regler[\"standard\"])\n",
        "        \n",
        "        # MGMT-stratifisering\n",
        "        if pasient.molekylær.mgmt_status == MGMTStatus.METYLERT:\n",
        "            if \"mgmt_metylert\" in regler:\n",
        "                anbefaling[\"tilleggsbehandling\"].extend(regler[\"mgmt_metylert\"])\n",
        "            anbefaling[\"prognostiske_kommentarer\"].append(\n",
        "                \"MGMT-metylert: Forventet bedre respons på temozolomid\"\n",
        "            )\n",
        "        elif pasient.molekylær.mgmt_status == MGMTStatus.UMETYLERT:\n",
        "            if \"mgmt_umetylert\" in regler:\n",
        "                anbefaling[\"tilleggsbehandling\"].extend(regler[\"mgmt_umetylert\"])\n",
        "        \n",
        "        # Alder-spesifikke anbefalinger\n",
        "        if pasient.klinisk.alder >= 65 and \"eldre_pasient\" in regler:\n",
        "            anbefaling[\"tilleggsbehandling\"].extend(regler[\"eldre_pasient\"])\n",
        "        \n",
        "        # IDH-mutert spesifikke\n",
        "        if tumor_type.startswith(\"astrocytom\") and \"vorasidenib\" in regler:\n",
        "            if pasient.molekylær.idh_status == IDHStatus.MUTERT:\n",
        "                anbefaling[\"anbefalte_studier\"].append(\n",
        "                    \"Vorasidenib (IDH-hemmer) godkjent for lavgradige IDH-muterte gliomer\"\n",
        "                )\n",
        "        \n",
        "        return anbefaling\n",
        "\n",
        "# Initialiser kunnskapsgrafen\n",
        "kg = GliomKunnskapsgraf()\n",
        "print(\"✓ Gliom-kunnskapsgraf initialisert\")\n",
        "print(f\"  - {len(kg.tumor_typer)} tumortyper definert\")\n",
        "print(f\"  - {len(kg.klassifikasjonsregler)} klassifikasjonsregler\")\n",
        "print(f\"  - Behandlingsregler for {len(kg.behandlingsregler)} tumortyper\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✓ Nevral analysator initialisert\n",
            "  - Modell: nnU-Net (BraTS 2023)\n",
            "  - Dice scores: ET=0.82, WT=0.91\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DEL 3: NEVRAL KOMPONENT - Simulert dyplæringsmodell for MRI-analyse\n",
        "# ============================================================================\n",
        "\n",
        "class NevralGliomAnalyse:\n",
        "    \"\"\"\n",
        "    Simulerer en dyplæringsmodell (f.eks. 3D U-Net) for MRI-analyse.\n",
        "    I praksis ville dette være en trent CNN på BraTS-data.\n",
        "    \n",
        "    Dette er den NEVRALE komponenten i vårt nevrosymbolske system.\n",
        "    \"\"\"\n",
        "    \n",
        "    def __init__(self):\n",
        "        \"\"\"\n",
        "        Simulerer en ferdig trent modell.\n",
        "        I virkeligheten: self.model = load_trained_model('brats_unet.h5')\n",
        "        \"\"\"\n",
        "        self.modell_navn = \"nnU-Net (BraTS 2023)\"\n",
        "        self.input_modaliteter = [\"T1\", \"T1Gd\", \"T2\", \"FLAIR\"]\n",
        "        self.output_klasser = [\"background\", \"enhancing\", \"edema\", \"necrosis\"]\n",
        "        \n",
        "        # Simulerte modellytelsestall (fra BraTS Challenge)\n",
        "        self.dice_scores = {\n",
        "            \"enhancing\": 0.82,\n",
        "            \"whole_tumor\": 0.91,\n",
        "            \"tumor_core\": 0.86\n",
        "        }\n",
        "    \n",
        "    def segmenter_tumor(self, mri_data: dict) -> MRIFeatures:\n",
        "        \"\"\"\n",
        "        Simulerer segmentering av tumor fra MRI.\n",
        "        \n",
        "        I praksis:\n",
        "        - Input: 4D array (T1, T1Gd, T2, FLAIR)\n",
        "        - Output: Segmenteringsmaske + kvantitative features\n",
        "        \"\"\"\n",
        "        # Simulerer output fra segmenteringsnettverk\n",
        "        np.random.seed(42)  # For reproduserbarhet\n",
        "        \n",
        "        # Simulerte volumetriske målinger (ml)\n",
        "        tumor_volum = np.random.uniform(20, 120)\n",
        "        enhancing = np.random.uniform(5, tumor_volum * 0.4)\n",
        "        nekrose = np.random.uniform(0, tumor_volum * 0.2)\n",
        "        ødem = np.random.uniform(10, tumor_volum * 0.8)\n",
        "        \n",
        "        return MRIFeatures(\n",
        "            tumor_volum_ml=round(tumor_volum, 1),\n",
        "            enhancing_volum_ml=round(enhancing, 1),\n",
        "            nekrose_volum_ml=round(nekrose, 1),\n",
        "            ødem_volum_ml=round(ødem, 1),\n",
        "            lokalisasjon=np.random.choice([\"frontal\", \"temporal\", \"parietal\", \"occipital\"]),\n",
        "            krysser_midtlinjen=np.random.choice([True, False]),\n",
        "            involverer_eloquent=np.random.choice([True, False], p=[0.3, 0.7])\n",
        "        )\n",
        "    \n",
        "    def prediker_molekylær_status(self, mri_features: MRIFeatures) -> Dict:\n",
        "        \"\"\"\n",
        "        Predikerer molekylær status fra MRI (radiogenomikk).\n",
        "        \n",
        "        Nyere forskning viser at visse MRI-features korrelerer med:\n",
        "        - IDH-mutasjonsstatus\n",
        "        - MGMT-metylering\n",
        "        - 1p/19q ko-delesjon\n",
        "        \"\"\"\n",
        "        # Simulerte prediksjoner med usikkerhet\n",
        "        prediksjoner = {}\n",
        "        \n",
        "        # IDH-prediksjon (høyere enhancing ratio → mer sannsynlig villtype)\n",
        "        if mri_features.enhancing_ratio > 0.3:\n",
        "            idh_villtype_prob = 0.75 + np.random.uniform(-0.1, 0.1)\n",
        "        else:\n",
        "            idh_villtype_prob = 0.35 + np.random.uniform(-0.1, 0.1)\n",
        "        \n",
        "        prediksjoner[\"idh_villtype\"] = {\n",
        "            \"sannsynlighet\": round(idh_villtype_prob, 2),\n",
        "            \"konfidensintervall\": (round(idh_villtype_prob - 0.15, 2), \n",
        "                                    round(idh_villtype_prob + 0.15, 2)),\n",
        "            \"modell_usikkerhet\": \"moderat\"\n",
        "        }\n",
        "        \n",
        "        # MGMT-prediksjon\n",
        "        mgmt_metylert_prob = 0.45 + np.random.uniform(-0.15, 0.15)\n",
        "        prediksjoner[\"mgmt_metylert\"] = {\n",
        "            \"sannsynlighet\": round(mgmt_metylert_prob, 2),\n",
        "            \"konfidensintervall\": (round(mgmt_metylert_prob - 0.2, 2),\n",
        "                                    round(mgmt_metylert_prob + 0.2, 2)),\n",
        "            \"modell_usikkerhet\": \"høy\"  # MGMT er vanskelig å predikere fra MRI\n",
        "        }\n",
        "        \n",
        "        # Overlevelsesestimat\n",
        "        if mri_features.nekrose_volum_ml > 10:\n",
        "            median_os = 12 + np.random.uniform(-3, 3)\n",
        "        elif mri_features.enhancing_ratio > 0.3:\n",
        "            median_os = 18 + np.random.uniform(-4, 4)\n",
        "        else:\n",
        "            median_os = 36 + np.random.uniform(-6, 6)\n",
        "        \n",
        "        prediksjoner[\"overlevelse\"] = {\n",
        "            \"median_måneder\": round(median_os, 0),\n",
        "            \"95_ci\": (round(median_os - 6, 0), round(median_os + 8, 0)),\n",
        "            \"modell\": \"Cox proportional hazards + Deep Surv\"\n",
        "        }\n",
        "        \n",
        "        return prediksjoner\n",
        "    \n",
        "    def beregn_usikkerhet(self, prediksjoner: Dict) -> Dict:\n",
        "        \"\"\"\n",
        "        Beregner epistemisk usikkerhet (modell-usikkerhet) via Monte Carlo Dropout.\n",
        "        \"\"\"\n",
        "        usikkerhet = {\n",
        "            \"type\": \"epistemisk\",\n",
        "            \"metode\": \"MC Dropout (100 forward passes)\",\n",
        "            \"vurdering\": {}\n",
        "        }\n",
        "        \n",
        "        for key, pred in prediksjoner.items():\n",
        "            if isinstance(pred, dict) and \"modell_usikkerhet\" in pred:\n",
        "                usikkerhet[\"vurdering\"][key] = pred[\"modell_usikkerhet\"]\n",
        "        \n",
        "        return usikkerhet\n",
        "\n",
        "# Initialiser nevral analysator\n",
        "nevral_modell = NevralGliomAnalyse()\n",
        "print(\"✓ Nevral analysator initialisert\")\n",
        "print(f\"  - Modell: {nevral_modell.modell_navn}\")\n",
        "print(f\"  - Dice scores: ET={nevral_modell.dice_scores['enhancing']:.2f}, \"\n",
        "      f\"WT={nevral_modell.dice_scores['whole_tumor']:.2f}\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 21,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✓ Nevrosymbolsk gliom-system initialisert\n",
            "  - Kunnskapsgraf: WHO 2021 CNS-klassifikasjon\n",
            "  - Nevral modell: nnU-Net + Radiogenomikk\n",
            "  - Integrasjon: Hybrid validering aktiv\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DEL 4: NEVROSYMBOLSK INTEGRASJON - Hybrid resonnering\n",
        "# ============================================================================\n",
        "\n",
        "class NevrosymbolskGliomSystem:\n",
        "    \"\"\"\n",
        "    Integrerer nevral bildeanalyse med symbolsk medisinsk kunnskap.\n",
        "    \n",
        "    Flyten er:\n",
        "    1. NEVRAL: MRI → Segmentering → Kvantitative features → Molekylær prediksjon\n",
        "    2. SYMBOLSK: Features + Prediksjon → Ontologi-matching → Klassifikasjon\n",
        "    3. SYMBOLSK: Klassifikasjon → Behandlingsregler → Anbefaling\n",
        "    4. HYBRID: Usikkerhetskvantifisering → Forklaring\n",
        "    \"\"\"\n",
        "    \n",
        "    def __init__(self, kunnskapsgraf: GliomKunnskapsgraf,\n",
        "                 nevral_modell: NevralGliomAnalyse):\n",
        "        self.kg = kunnskapsgraf\n",
        "        self.nn = nevral_modell\n",
        "        \n",
        "    def analyser_pasient(self, pasient: GliomPasient, \n",
        "                          verifiser_molekylært: bool = True) -> Dict:\n",
        "        \"\"\"\n",
        "        Komplett nevrosymbolsk analyse av en gliom-pasient.\n",
        "        \"\"\"\n",
        "        resultat = {\n",
        "            \"pasient_id\": pasient.pasient_id,\n",
        "            \"nevral_analyse\": {},\n",
        "            \"symbolsk_klassifikasjon\": {},\n",
        "            \"hybrid_validering\": {},\n",
        "            \"behandlingsanbefaling\": {},\n",
        "            \"forklaring\": {}\n",
        "        }\n",
        "        \n",
        "        # ==== STEG 1: Nevral analyse ====\n",
        "        print(f\"\\n{'='*60}\")\n",
        "        print(f\"NEVROSYMBOLSK ANALYSE: Pasient {pasient.pasient_id}\")\n",
        "        print(f\"{'='*60}\")\n",
        "        \n",
        "        print(\"\\n[STEG 1] NEVRAL KOMPONENT: MRI-analyse\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        # Bruk pasientens MRI-features (i praksis: segmenter fra rå MRI)\n",
        "        mri = pasient.mri\n",
        "        print(f\"  Tumorvolum: {mri.tumor_volum_ml} ml\")\n",
        "        print(f\"  Enhancing: {mri.enhancing_volum_ml} ml ({mri.enhancing_ratio:.1%})\")\n",
        "        print(f\"  Nekrose: {mri.nekrose_volum_ml} ml\")\n",
        "        print(f\"  Ødem: {mri.ødem_volum_ml} ml\")\n",
        "        print(f\"  Lokalisasjon: {mri.lokalisasjon}\")\n",
        "        \n",
        "        # Radiogenomikk-prediksjoner\n",
        "        prediksjoner = self.nn.prediker_molekylær_status(mri)\n",
        "        resultat[\"nevral_analyse\"][\"mri_features\"] = {\n",
        "            \"tumor_volum\": mri.tumor_volum_ml,\n",
        "            \"enhancing_ratio\": round(mri.enhancing_ratio, 2),\n",
        "            \"har_nekrose\": mri.nekrose_volum_ml > 0\n",
        "        }\n",
        "        resultat[\"nevral_analyse\"][\"molekylær_prediksjon\"] = prediksjoner\n",
        "        \n",
        "        print(f\"\\n  Radiogenomikk-prediksjoner:\")\n",
        "        print(f\"    IDH-villtype: {prediksjoner['idh_villtype']['sannsynlighet']:.0%} \"\n",
        "              f\"(usikkerhet: {prediksjoner['idh_villtype']['modell_usikkerhet']})\")\n",
        "        print(f\"    MGMT-metylert: {prediksjoner['mgmt_metylert']['sannsynlighet']:.0%} \"\n",
        "              f\"(usikkerhet: {prediksjoner['mgmt_metylert']['modell_usikkerhet']})\")\n",
        "        \n",
        "        # ==== STEG 2: Symbolsk klassifikasjon ====\n",
        "        print(\"\\n[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        tumor_type, forklaring = self.kg.klassifiser_tumor(pasient)\n",
        "        resultat[\"symbolsk_klassifikasjon\"][\"tumor_type\"] = tumor_type\n",
        "        resultat[\"symbolsk_klassifikasjon\"][\"forklaring\"] = forklaring\n",
        "        \n",
        "        print(f\"  Anvendte regler:\")\n",
        "        for regel in forklaring[\"anvendte_regler\"]:\n",
        "            print(f\"    → {regel}\")\n",
        "        print(f\"  Konklusjon: {forklaring['konklusjon']}\")\n",
        "        \n",
        "        if forklaring[\"usikkerhet\"]:\n",
        "            print(f\"  ⚠ Usikkerhet: {'; '.join(forklaring['usikkerhet'])}\")\n",
        "        \n",
        "        # ==== STEG 3: Hybrid validering ====\n",
        "        print(\"\\n[STEG 3] HYBRID VALIDERING: Konsistenssjekk\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        validering = self._valider_konsistens(pasient, prediksjoner, tumor_type)\n",
        "        resultat[\"hybrid_validering\"] = validering\n",
        "        \n",
        "        if validering[\"konsistent\"]:\n",
        "            print(f\"  ✓ Nevrale prediksjoner er KONSISTENTE med symbolsk klassifikasjon\")\n",
        "        else:\n",
        "            print(f\"  ⚠ INKONSISTENS oppdaget:\")\n",
        "            for advarsel in validering[\"advarsler\"]:\n",
        "                print(f\"    → {advarsel}\")\n",
        "        \n",
        "        # ==== STEG 4: Behandlingsanbefaling ====\n",
        "        print(\"\\n[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        behandling = self.kg.generer_behandlingsanbefaling(pasient, tumor_type)\n",
        "        resultat[\"behandlingsanbefaling\"] = behandling\n",
        "        \n",
        "        print(f\"  Primær behandling:\")\n",
        "        for beh in behandling[\"primær_behandling\"]:\n",
        "            print(f\"    • {beh}\")\n",
        "        \n",
        "        if behandling[\"tilleggsbehandling\"]:\n",
        "            print(f\"  Tilleggsbehandling (basert på molekylær profil):\")\n",
        "            for beh in behandling[\"tilleggsbehandling\"]:\n",
        "                print(f\"    • {beh}\")\n",
        "        \n",
        "        if behandling[\"prognostiske_kommentarer\"]:\n",
        "            print(f\"  Prognostiske kommentarer:\")\n",
        "            for kom in behandling[\"prognostiske_kommentarer\"]:\n",
        "                print(f\"    → {kom}\")\n",
        "        \n",
        "        # ==== STEG 5: Generert forklaring ====\n",
        "        print(\"\\n[STEG 5] FORKLARING FOR KLINIKER\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        forklaring_tekst = self._generer_forklaring(pasient, resultat)\n",
        "        resultat[\"forklaring\"][\"tekst\"] = forklaring_tekst\n",
        "        print(forklaring_tekst)\n",
        "        \n",
        "        return resultat\n",
        "    \n",
        "    def _valider_konsistens(self, pasient: GliomPasient, \n",
        "                             nevrale_pred: Dict, \n",
        "                             tumor_type: str) -> Dict:\n",
        "        \"\"\"\n",
        "        Sjekker konsistens mellom nevrale prediksjoner og symbolsk klassifikasjon.\n",
        "        Dette er KJERNEN i nevrosymbolsk AI: bruke symbolsk kunnskap til å \n",
        "        validere nevrale output.\n",
        "        \"\"\"\n",
        "        validering = {\"konsistent\": True, \"advarsler\": [], \"bekreftelser\": []}\n",
        "        \n",
        "        # Hent faktisk molekylær status\n",
        "        faktisk_idh = pasient.molekylær.idh_status\n",
        "        predikert_idh_villtype_prob = nevrale_pred[\"idh_villtype\"][\"sannsynlighet\"]\n",
        "        \n",
        "        # Sjekk IDH-konsistens\n",
        "        if faktisk_idh == IDHStatus.VILLTYPE:\n",
        "            if predikert_idh_villtype_prob < 0.5:\n",
        "                validering[\"konsistent\"] = False\n",
        "                validering[\"advarsler\"].append(\n",
        "                    f\"Nevral modell predikerer IDH-mutert ({1-predikert_idh_villtype_prob:.0%}), \"\n",
        "                    f\"men faktisk status er IDH-villtype\"\n",
        "                )\n",
        "            else:\n",
        "                validering[\"bekreftelser\"].append(\"IDH-prediksjon samsvarer med faktisk status\")\n",
        "        \n",
        "        elif faktisk_idh == IDHStatus.MUTERT:\n",
        "            if predikert_idh_villtype_prob > 0.5:\n",
        "                validering[\"konsistent\"] = False\n",
        "                validering[\"advarsler\"].append(\n",
        "                    f\"Nevral modell predikerer IDH-villtype ({predikert_idh_villtype_prob:.0%}), \"\n",
        "                    f\"men faktisk status er IDH-mutert\"\n",
        "                )\n",
        "            else:\n",
        "                validering[\"bekreftelser\"].append(\"IDH-prediksjon samsvarer med faktisk status\")\n",
        "        \n",
        "        # Sjekk MRI-features mot tumortype (ontologi-basert validering)\n",
        "        if tumor_type == \"glioblastom\":\n",
        "            if pasient.mri.enhancing_ratio < 0.1:\n",
        "                validering[\"advarsler\"].append(\n",
        "                    \"Lav enhancing ratio (<10%) er uvanlig for glioblastom - vurder diagnosen\"\n",
        "                )\n",
        "        \n",
        "        if tumor_type in [\"astrocytom_2\", \"oligodendrogliom_2\"]:\n",
        "            if pasient.mri.nekrose_volum_ml > 5:\n",
        "                validering[\"konsistent\"] = False\n",
        "                validering[\"advarsler\"].append(\n",
        "                    \"Nekrose påvist, men klassifisert som grad 2 - oppgrader til grad 3/4\"\n",
        "                )\n",
        "        \n",
        "        return validering\n",
        "    \n",
        "    def _generer_forklaring(self, pasient: GliomPasient, resultat: Dict) -> str:\n",
        "        \"\"\"\n",
        "        Genererer en menneskelesbar forklaring av analysen.\n",
        "        \"\"\"\n",
        "        tumor_type = resultat[\"symbolsk_klassifikasjon\"][\"tumor_type\"]\n",
        "        tumor_info = self.kg.tumor_typer.get(tumor_type, {})\n",
        "        \n",
        "        forklaring = f\"\"\"\n",
        "SAMMENDRAG FOR PASIENT {pasient.pasient_id}:\n",
        "\n",
        "DIAGNOSE: {tumor_info.get('navn', tumor_type.upper())}\n",
        "  - WHO-grad: {tumor_info.get('grad', 'ukjent').name if hasattr(tumor_info.get('grad'), 'name') else 'ukjent'}\n",
        "  - Median overlevelse: {tumor_info.get('median_overlevelse_måneder', 'ukjent')} måneder\n",
        "\n",
        "MOLEKYLÆR PROFIL:\n",
        "  - IDH-status: {pasient.molekylær.idh_status.value}\n",
        "  - MGMT-status: {pasient.molekylær.mgmt_status.value}\n",
        "  - 1p/19q ko-delesjon: {'Ja' if pasient.molekylær.kodeletion_1p19q else 'Nei'}\n",
        "\n",
        "KLINISK:\n",
        "  - Alder: {pasient.klinisk.alder} år\n",
        "  - Karnofsky: {pasient.klinisk.karnofsky_score}\n",
        "\n",
        "VALIDERING: {'Konsistent' if resultat['hybrid_validering']['konsistent'] else 'Se advarsler ovenfor'}\n",
        "\"\"\"\n",
        "        return forklaring\n",
        "\n",
        "# Initialiser det nevrosymbolske systemet\n",
        "ns_system = NevrosymbolskGliomSystem(kg, nevral_modell)\n",
        "print(\"✓ Nevrosymbolsk gliom-system initialisert\")\n",
        "print(\"  - Kunnskapsgraf: WHO 2021 CNS-klassifikasjon\")\n",
        "print(\"  - Nevral modell: nnU-Net + Radiogenomikk\")\n",
        "print(\"  - Integrasjon: Hybrid validering aktiv\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "### Demonstrasjon: Analyse av gliom-pasienter\n",
        "\n",
        "Vi demonstrerer nå det nevrosymbolske systemet på tre typiske pasientcase:\n",
        "\n",
        "1. **Pasient A**: Klassisk glioblastom (IDH-villtype, eldre pasient)\n",
        "2. **Pasient B**: Oligodendrogliom (IDH-mutert, 1p/19q ko-deletert)\n",
        "3. **Pasient C**: Astrocytom med inkonsistens mellom MRI og molekylær profil\n",
        "\n",
        "Dette illustrerer hvordan systemet:\n",
        "- Kombinerer nevrale prediksjoner med symbolsk klassifikasjon\n",
        "- Oppdager inkonsistenser mellom datakilder\n",
        "- Genererer forklarbare behandlingsanbefalinger"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 22,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "============================================================\n",
            "NEVROSYMBOLSK ANALYSE: Pasient GBM-001\n",
            "============================================================\n",
            "\n",
            "[STEG 1] NEVRAL KOMPONENT: MRI-analyse\n",
            "----------------------------------------\n",
            "  Tumorvolum: 65.3 ml\n",
            "  Enhancing: 28.7 ml (44.0%)\n",
            "  Nekrose: 12.4 ml\n",
            "  Ødem: 45.2 ml\n",
            "  Lokalisasjon: temporal\n",
            "\n",
            "  Radiogenomikk-prediksjoner:\n",
            "    IDH-villtype: 85% (usikkerhet: moderat)\n",
            "    MGMT-metylert: 59% (usikkerhet: høy)\n",
            "\n",
            "[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\n",
            "----------------------------------------\n",
            "  Anvendte regler:\n",
            "    → IDH-villtype påvist\n",
            "    → Glioblastom-markører: TERT-promoter mutasjon, EGFR-amplifisering, +7/-10 kromosomendringer\n",
            "  Konklusjon: Glioblastom, IDH-villtype, grad 4\n",
            "\n",
            "[STEG 3] HYBRID VALIDERING: Konsistenssjekk\n",
            "----------------------------------------\n",
            "  ✓ Nevrale prediksjoner er KONSISTENTE med symbolsk klassifikasjon\n",
            "\n",
            "[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\n",
            "----------------------------------------\n",
            "  Primær behandling:\n",
            "    • Maksimal sikker reseksjon\n",
            "    • Temozolomid + stråling (Stupp-protokoll)\n",
            "  Tilleggsbehandling (basert på molekylær profil):\n",
            "    • Vurder alternativ til temozolomid\n",
            "    • Kliniske studier anbefales\n",
            "    • Hypofraksjonert stråling\n",
            "    • Temozolomid monoterapi hvis MGMT-metylert\n",
            "\n",
            "[STEG 5] FORKLARING FOR KLINIKER\n",
            "----------------------------------------\n",
            "\n",
            "SAMMENDRAG FOR PASIENT GBM-001:\n",
            "\n",
            "DIAGNOSE: Glioblastom, IDH-villtype\n",
            "  - WHO-grad: GRAD_4\n",
            "  - Median overlevelse: 15 måneder\n",
            "\n",
            "MOLEKYLÆR PROFIL:\n",
            "  - IDH-status: IDH-villtype\n",
            "  - MGMT-status: MGMT-umetylert\n",
            "  - 1p/19q ko-delesjon: Nei\n",
            "\n",
            "KLINISK:\n",
            "  - Alder: 68 år\n",
            "  - Karnofsky: 70\n",
            "\n",
            "VALIDERING: Konsistent\n",
            "\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DEMONSTRASJON: Tre pasientcase\n",
        "# ============================================================================\n",
        "\n",
        "# --- PASIENT A: Klassisk glioblastom ---\n",
        "pasient_a = GliomPasient(\n",
        "    pasient_id=\"GBM-001\",\n",
        "    molekylær=MolekylærProfil(\n",
        "        idh_status=IDHStatus.VILLTYPE,\n",
        "        mgmt_status=MGMTStatus.UMETYLERT,\n",
        "        tert_promoter=True,\n",
        "        egfr_amplifisering=True,\n",
        "        kromosom_7_gain=True,\n",
        "        kromosom_10_loss=True\n",
        "    ),\n",
        "    mri=MRIFeatures(\n",
        "        tumor_volum_ml=65.3,\n",
        "        enhancing_volum_ml=28.7,\n",
        "        nekrose_volum_ml=12.4,\n",
        "        ødem_volum_ml=45.2,\n",
        "        lokalisasjon=\"temporal\",\n",
        "        krysser_midtlinjen=False,\n",
        "        involverer_eloquent=True\n",
        "    ),\n",
        "    klinisk=KliniskProfil(\n",
        "        alder=68,\n",
        "        karnofsky_score=70,\n",
        "        symptom_varighet_uker=4,\n",
        "        reseksjonsstatus=\"STR\"  # Subtotal resection\n",
        "    ),\n",
        "    histologi=\"glioblastom\"\n",
        ")\n",
        "\n",
        "# Kjør analyse\n",
        "resultat_a = ns_system.analyser_pasient(pasient_a)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 23,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "============================================================\n",
            "NEVROSYMBOLSK ANALYSE: Pasient OLIGO-042\n",
            "============================================================\n",
            "\n",
            "[STEG 1] NEVRAL KOMPONENT: MRI-analyse\n",
            "----------------------------------------\n",
            "  Tumorvolum: 32.1 ml\n",
            "  Enhancing: 3.2 ml (10.0%)\n",
            "  Nekrose: 0.0 ml\n",
            "  Ødem: 18.5 ml\n",
            "  Lokalisasjon: frontal\n",
            "\n",
            "  Radiogenomikk-prediksjoner:\n",
            "    IDH-villtype: 44% (usikkerhet: moderat)\n",
            "    MGMT-metylert: 41% (usikkerhet: høy)\n",
            "\n",
            "[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\n",
            "----------------------------------------\n",
            "  Anvendte regler:\n",
            "    → IDH-mutasjon påvist\n",
            "    → 1p/19q ko-delesjon påvist → Oligodendrogliom\n",
            "  Konklusjon: Oligodendrogliom, grad 2\n",
            "\n",
            "[STEG 3] HYBRID VALIDERING: Konsistenssjekk\n",
            "----------------------------------------\n",
            "  ✓ Nevrale prediksjoner er KONSISTENTE med symbolsk klassifikasjon\n",
            "\n",
            "[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\n",
            "----------------------------------------\n",
            "  Primær behandling:\n",
            "  Prognostiske kommentarer:\n",
            "    → MGMT-metylert: Forventet bedre respons på temozolomid\n",
            "\n",
            "[STEG 5] FORKLARING FOR KLINIKER\n",
            "----------------------------------------\n",
            "\n",
            "SAMMENDRAG FOR PASIENT OLIGO-042:\n",
            "\n",
            "DIAGNOSE: Oligodendrogliom, IDH-mutert, 1p/19q ko-deletert, grad 2\n",
            "  - WHO-grad: GRAD_2\n",
            "  - Median overlevelse: 156 måneder\n",
            "\n",
            "MOLEKYLÆR PROFIL:\n",
            "  - IDH-status: IDH-mutert\n",
            "  - MGMT-status: MGMT-metylert\n",
            "  - 1p/19q ko-delesjon: Ja\n",
            "\n",
            "KLINISK:\n",
            "  - Alder: 42 år\n",
            "  - Karnofsky: 90\n",
            "\n",
            "VALIDERING: Konsistent\n",
            "\n"
          ]
        }
      ],
      "source": [
        "# --- PASIENT B: Oligodendrogliom med gunstig prognose ---\n",
        "pasient_b = GliomPasient(\n",
        "    pasient_id=\"OLIGO-042\",\n",
        "    molekylær=MolekylærProfil(\n",
        "        idh_status=IDHStatus.MUTERT,\n",
        "        mgmt_status=MGMTStatus.METYLERT,\n",
        "        kodeletion_1p19q=True,  # Patognomonisk for oligodendrogliom\n",
        "        atrx_tap=False  # ATRX er bevart ved oligodendrogliom\n",
        "    ),\n",
        "    mri=MRIFeatures(\n",
        "        tumor_volum_ml=32.1,\n",
        "        enhancing_volum_ml=3.2,  # Lavt enhancing (typisk for lavgradig)\n",
        "        nekrose_volum_ml=0.0,    # Ingen nekrose\n",
        "        ødem_volum_ml=18.5,\n",
        "        lokalisasjon=\"frontal\",\n",
        "        krysser_midtlinjen=False,\n",
        "        involverer_eloquent=False\n",
        "    ),\n",
        "    klinisk=KliniskProfil(\n",
        "        alder=42,\n",
        "        karnofsky_score=90,  # God funksjonsstatus\n",
        "        symptom_varighet_uker=12,  # Langvarig symptom (typisk lavgradig)\n",
        "        reseksjonsstatus=\"GTR\"  # Gross total resection\n",
        "    ),\n",
        "    histologi=\"oligodendrogliom\"\n",
        ")\n",
        "\n",
        "# Kjør analyse\n",
        "resultat_b = ns_system.analyser_pasient(pasient_b)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 24,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "============================================================\n",
            "NEVROSYMBOLSK ANALYSE: Pasient ASTRO-117\n",
            "============================================================\n",
            "\n",
            "[STEG 1] NEVRAL KOMPONENT: MRI-analyse\n",
            "----------------------------------------\n",
            "  Tumorvolum: 48.7 ml\n",
            "  Enhancing: 18.3 ml (37.6%)\n",
            "  Nekrose: 6.2 ml\n",
            "  Ødem: 35.1 ml\n",
            "  Lokalisasjon: parietal\n",
            "\n",
            "  Radiogenomikk-prediksjoner:\n",
            "    IDH-villtype: 69% (usikkerhet: moderat)\n",
            "    MGMT-metylert: 31% (usikkerhet: høy)\n",
            "\n",
            "[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\n",
            "----------------------------------------\n",
            "  Anvendte regler:\n",
            "    → IDH-mutasjon påvist\n",
            "    → Ingen 1p/19q ko-delesjon → Astrocytom\n",
            "    → ATRX-tap bekrefter astrocytom-linje\n",
            "  Konklusjon: Astrocytom, IDH-mutert, grad 4\n",
            "\n",
            "[STEG 3] HYBRID VALIDERING: Konsistenssjekk\n",
            "----------------------------------------\n",
            "  ⚠ INKONSISTENS oppdaget:\n",
            "    → Nevral modell predikerer IDH-villtype (69%), men faktisk status er IDH-mutert\n",
            "\n",
            "[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\n",
            "----------------------------------------\n",
            "  Primær behandling:\n",
            "  Prognostiske kommentarer:\n",
            "    → MGMT-metylert: Forventet bedre respons på temozolomid\n",
            "\n",
            "[STEG 5] FORKLARING FOR KLINIKER\n",
            "----------------------------------------\n",
            "\n",
            "SAMMENDRAG FOR PASIENT ASTRO-117:\n",
            "\n",
            "DIAGNOSE: Astrocytom, IDH-mutert, grad 4\n",
            "  - WHO-grad: GRAD_4\n",
            "  - Median overlevelse: 36 måneder\n",
            "\n",
            "MOLEKYLÆR PROFIL:\n",
            "  - IDH-status: IDH-mutert\n",
            "  - MGMT-status: MGMT-metylert\n",
            "  - 1p/19q ko-delesjon: Nei\n",
            "\n",
            "KLINISK:\n",
            "  - Alder: 51 år\n",
            "  - Karnofsky: 80\n",
            "\n",
            "VALIDERING: Se advarsler ovenfor\n",
            "\n"
          ]
        }
      ],
      "source": [
        "# --- PASIENT C: Astrocytom med diagnostisk usikkerhet ---\n",
        "# Denne pasienten illustrerer viktigheten av nevrosymbolsk validering:\n",
        "# MRI-features kan tyde på høyere grad enn molekylær profil tilsier\n",
        "\n",
        "pasient_c = GliomPasient(\n",
        "    pasient_id=\"ASTRO-117\",\n",
        "    molekylær=MolekylærProfil(\n",
        "        idh_status=IDHStatus.MUTERT,\n",
        "        mgmt_status=MGMTStatus.METYLERT,\n",
        "        kodeletion_1p19q=False,\n",
        "        atrx_tap=True  # Bekrefter astrocytær differensiering\n",
        "    ),\n",
        "    mri=MRIFeatures(\n",
        "        tumor_volum_ml=48.7,\n",
        "        enhancing_volum_ml=18.3,  # Betydelig enhancing\n",
        "        nekrose_volum_ml=6.2,     # Nekrose tilstede!\n",
        "        ødem_volum_ml=35.1,\n",
        "        lokalisasjon=\"parietal\",\n",
        "        krysser_midtlinjen=True,  # Krysser corpus callosum\n",
        "        involverer_eloquent=True\n",
        "    ),\n",
        "    klinisk=KliniskProfil(\n",
        "        alder=51,\n",
        "        karnofsky_score=80,\n",
        "        symptom_varighet_uker=6,\n",
        "        reseksjonsstatus=\"biopsi\"  # Kun biopsi mulig\n",
        "    ),\n",
        "    histologi=\"anaplastisk_astrocytom\"\n",
        ")\n",
        "\n",
        "# Kjør analyse - dette vil identifisere potensielle problemstillinger\n",
        "resultat_c = ns_system.analyser_pasient(pasient_c)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 25,
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 1400x1000 with 4 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "✓ Figur lagret som 'gliom_analyse_sammenligning.png'\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# VISUALISERING: Sammenligning av pasientene\n",
        "# ============================================================================\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "\n",
        "def visualiser_pasient_sammenligning(pasienter: List[GliomPasient], \n",
        "                                      resultater: List[Dict]):\n",
        "    \"\"\"\n",
        "    Visualiserer og sammenligner de tre pasientcasene.\n",
        "    \"\"\"\n",
        "    fig, axes = plt.subplots(2, 2, figsize=(14, 10))\n",
        "    \n",
        "    # --- Plot 1: MRI-volumetriske features ---\n",
        "    ax1 = axes[0, 0]\n",
        "    x = np.arange(len(pasienter))\n",
        "    width = 0.2\n",
        "    \n",
        "    enhancing = [p.mri.enhancing_volum_ml for p in pasienter]\n",
        "    nekrose = [p.mri.nekrose_volum_ml for p in pasienter]\n",
        "    ødem = [p.mri.ødem_volum_ml for p in pasienter]\n",
        "    \n",
        "    ax1.bar(x - width, enhancing, width, label='Enhancing', color='#e74c3c')\n",
        "    ax1.bar(x, nekrose, width, label='Nekrose', color='#2c3e50')\n",
        "    ax1.bar(x + width, ødem, width, label='Ødem', color='#3498db')\n",
        "    \n",
        "    ax1.set_ylabel('Volum (ml)')\n",
        "    ax1.set_xlabel('Pasient')\n",
        "    ax1.set_title('MRI: Volumetriske målinger')\n",
        "    ax1.set_xticks(x)\n",
        "    ax1.set_xticklabels([p.pasient_id for p in pasienter])\n",
        "    ax1.legend()\n",
        "    ax1.grid(axis='y', alpha=0.3)\n",
        "    \n",
        "    # --- Plot 2: Prognose-sammenligning ---\n",
        "    ax2 = axes[0, 1]\n",
        "    tumor_typer = [r[\"symbolsk_klassifikasjon\"][\"tumor_type\"] for r in resultater]\n",
        "    overlevelser = []\n",
        "    \n",
        "    for tt in tumor_typer:\n",
        "        info = kg.tumor_typer.get(tt, {})\n",
        "        overlevelser.append(info.get(\"median_overlevelse_måneder\", 0))\n",
        "    \n",
        "    colors = ['#c0392b', '#27ae60', '#f39c12']\n",
        "    bars = ax2.bar(x, overlevelser, color=colors, edgecolor='black', linewidth=1.5)\n",
        "    \n",
        "    ax2.set_ylabel('Median overlevelse (måneder)')\n",
        "    ax2.set_xlabel('Pasient')\n",
        "    ax2.set_title('Prognose: Median overlevelse')\n",
        "    ax2.set_xticks(x)\n",
        "    ax2.set_xticklabels([p.pasient_id for p in pasienter])\n",
        "    \n",
        "    # Legg til verdier på søylene\n",
        "    for bar, val in zip(bars, overlevelser):\n",
        "        ax2.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 2,\n",
        "                 f'{val:.0f}', ha='center', va='bottom', fontweight='bold')\n",
        "    ax2.grid(axis='y', alpha=0.3)\n",
        "    \n",
        "    # --- Plot 3: Molekylær profil som heatmap ---\n",
        "    ax3 = axes[1, 0]\n",
        "    \n",
        "    profil_data = []\n",
        "    for p in pasienter:\n",
        "        mol = p.molekylær\n",
        "        profil_data.append([\n",
        "            1 if mol.idh_status == IDHStatus.MUTERT else 0,\n",
        "            1 if mol.mgmt_status == MGMTStatus.METYLERT else 0,\n",
        "            1 if mol.kodeletion_1p19q else 0,\n",
        "            1 if mol.atrx_tap else 0,\n",
        "            1 if mol.tert_promoter else 0,\n",
        "            1 if mol.egfr_amplifisering else 0\n",
        "        ])\n",
        "    \n",
        "    profil_matrix = np.array(profil_data)\n",
        "    im = ax3.imshow(profil_matrix.T, cmap='RdYlGn', aspect='auto', vmin=0, vmax=1)\n",
        "    \n",
        "    ax3.set_yticks(range(6))\n",
        "    ax3.set_yticklabels(['IDH-mut', 'MGMT-met', '1p/19q', 'ATRX-tap', \n",
        "                         'TERT-prom', 'EGFR-amp'])\n",
        "    ax3.set_xticks(range(len(pasienter)))\n",
        "    ax3.set_xticklabels([p.pasient_id for p in pasienter])\n",
        "    ax3.set_title('Molekylær profil (Grønn=Positiv, Rød=Negativ)')\n",
        "    \n",
        "    # Legg til verdier i cellene\n",
        "    for i in range(len(pasienter)):\n",
        "        for j in range(6):\n",
        "            text = '✓' if profil_matrix[i, j] else '✗'\n",
        "            ax3.text(i, j, text, ha='center', va='center', \n",
        "                     color='white', fontsize=12, fontweight='bold')\n",
        "    \n",
        "    # --- Plot 4: Validerings-status ---\n",
        "    ax4 = axes[1, 1]\n",
        "    \n",
        "    # Forbered data\n",
        "    kategorier = ['Konsistent', 'Advarsler']\n",
        "    konsistent = [1 if r[\"hybrid_validering\"][\"konsistent\"] else 0 for r in resultater]\n",
        "    advarsler = [len(r[\"hybrid_validering\"][\"advarsler\"]) for r in resultater]\n",
        "    \n",
        "    x_pos = np.arange(len(pasienter))\n",
        "    \n",
        "    ax4.barh([0], [sum(konsistent)], color='#27ae60', label='Konsistent', height=0.3)\n",
        "    ax4.barh([0.4], [len(pasienter) - sum(konsistent)], color='#e74c3c', \n",
        "             label='Inkonsistent', height=0.3)\n",
        "    \n",
        "    ax4.set_xlim(0, len(pasienter) + 0.5)\n",
        "    ax4.set_yticks([0, 0.4])\n",
        "    ax4.set_yticklabels(['Konsistent', 'Inkonsistent'])\n",
        "    ax4.set_xlabel('Antall pasienter')\n",
        "    ax4.set_title('Hybrid validering: Konsistenssjekk')\n",
        "    ax4.legend(loc='lower right')\n",
        "    \n",
        "    plt.tight_layout()\n",
        "    plt.savefig('gliom_analyse_sammenligning.png', dpi=150, bbox_inches='tight')\n",
        "    plt.show()\n",
        "    \n",
        "    print(\"\\n✓ Figur lagret som 'gliom_analyse_sammenligning.png'\")\n",
        "\n",
        "# Kjør visualisering\n",
        "visualiser_pasient_sammenligning(\n",
        "    [pasient_a, pasient_b, pasient_c],\n",
        "    [resultat_a, resultat_b, resultat_c]\n",
        ")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "### Oppsummering av gliom-casestudien\n",
        "\n",
        "#### Hva demonstrerte vi?\n",
        "\n",
        "| Komponent | Teknologi | Funksjon |\n",
        "|-----------|-----------|----------|\n",
        "| **Nevral** | 3D U-Net, Radiogenomikk | MRI-segmentering, molekylær prediksjon |\n",
        "| **Symbolsk** | Kunnskapsgraf, Ontologi | WHO-klassifikasjon, behandlingsregler |\n",
        "| **Hybrid** | Konsistenssjekk | Validering, forklaring |\n",
        "\n",
        "#### Fordeler med nevrosymbolsk tilnærming for gliom\n",
        "\n",
        "1. **Forklarbarhet**: Klinikeren kan følge resonnementet fra MRI → Klassifikasjon → Behandling\n",
        "2. **Robusthet**: Symbolsk validering fanger opp feil i nevrale prediksjoner\n",
        "3. **Oppdaterbarhet**: Nye WHO-regler kan enkelt legges til kunnskapsgrafen\n",
        "4. **Datamangel**: Kan utnytte eksisterende medisinsk kunnskap når data er begrenset\n",
        "\n",
        "#### Klinisk relevans\n",
        "\n",
        "- **Beslutningsstøtte**: Hjelper nevrokirurger og onkologer med kompleks klassifikasjon\n",
        "- **Kvalitetssikring**: Automatisk sjekk av molekylær-histologisk samsvar\n",
        "- **Prognose**: Kombinerer bildebaserte og molekylære biomarkører\n",
        "- **Personalisert behandling**: Stratifisering basert på MGMT, IDH, etc.\n",
        "\n",
        "#### Begrensninger og fremtidige retninger\n",
        "\n",
        "- **Data**: Krever validering på større kohorter (f.eks. TCGA, CGGA)\n",
        "- **Usikkerhet**: Bedre kvantifisering av epistemisk usikkerhet\n",
        "- **Integrasjon**: Kobling til elektronisk pasientjournal (EPJ)\n",
        "- **Læring**: Kontinuerlig oppdatering basert på nye utfall"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "### Agentisk AI: Neste steg for klinisk beslutningsstøtte\n",
        "\n",
        "**Agentisk AI** (agentic AI) representerer en naturlig utvidelse av nevrosymbolsk AI der systemet kan:\n",
        "- **Handle autonomt**: Ta initiativ til handlinger basert på mål\n",
        "- **Planlegge**: Bryte ned komplekse oppgaver i delmål\n",
        "- **Bruke verktøy**: Integrere med eksterne systemer og databaser\n",
        "- **Resonnere**: Reflektere over egne handlinger og tilpasse strategi\n",
        "- **Lære**: Forbedre seg basert på feedback\n",
        "\n",
        "#### Hvordan agentisk AI kunne forbedre gliom-systemet\n",
        "\n",
        "I vårt nevrosymbolske gliom-system kunne en **AI-agent** orkestrere hele arbeidsflyten:\n",
        "\n",
        "```\n",
        "┌─────────────────────────────────────────────────────────────────────┐\n",
        "│                     AGENTISK GLIOM-ASSISTENT                        │\n",
        "├─────────────────────────────────────────────────────────────────────┤\n",
        "│                                                                     │\n",
        "│  PASIENTHENVISNING MOTTAS                                           │\n",
        "│          ↓                                                          │\n",
        "│  ┌─────────────────┐                                                │\n",
        "│  │   AI-AGENT      │ ← Mål: \"Gi optimal behandlingsanbefaling\"      │\n",
        "│  └────────┬────────┘                                                │\n",
        "│           │                                                         │\n",
        "│  PLANLEGGING: Hvilke steg trengs?                                   │\n",
        "│           │                                                         │\n",
        "│           ├──→ [1] Hent MRI fra PACS                                │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [2] Kjør segmentering (nnU-Net)                      │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [3] Hent molekylære prøvesvar fra lab-system         │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [4] Klassifiser tumor (WHO 2021)                     │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [5] Søk i litteraturdatabaser (PubMed, etc.)         │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [6] Finn lignende pasienter i biobank                │\n",
        "│           │         ↓                                               │\n",
        "│           ├──→ [7] Generer behandlingsanbefaling                    │\n",
        "│           │         ↓                                               │\n",
        "│           └──→ [8] Skriv rapport til MDT-møte                       │\n",
        "│                                                                     │\n",
        "│  REFLEKSJON: Er resultatet konsistent? Trenger jeg mer info?        │\n",
        "│                                                                     │\n",
        "└─────────────────────────────────────────────────────────────────────┘\n",
        "```\n",
        "\n",
        "#### Nøkkelegenskaper ved agentisk gliom-AI\n",
        "\n",
        "| Egenskap | Beskrivelse | Eksempel |\n",
        "|----------|-------------|----------|\n",
        "| **Verktøybruk** | Kaller eksterne API-er og systemer | Henter bilder fra PACS, søker i PubMed |\n",
        "| **Planlegging** | Dekomponerer komplekse mål | \"Klassifiser tumor\" → flere delmål |\n",
        "| **Minne** | Husker tidligere interaksjoner | Oppfølging av samme pasient over tid |\n",
        "| **Refleksjon** | Evaluerer egne handlinger | \"Er IDH-prediksjon konsistent med histologi?\" |\n",
        "| **Human-in-the-loop** | Involverer kliniker ved usikkerhet | \"Usikker klassifikasjon - vennligst verifiser\" |"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 26,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✓ Agentisk AI-rammeverk definert\n",
            "  - Verktøy: PACS, PubMed, Biobank\n",
            "  - Kapabiliteter: Planlegging, Refleksjon, Human-in-the-loop\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# AGENTISK AI: Simulert agent for gliom-analyse\n",
        "# ============================================================================\n",
        "\n",
        "from abc import ABC, abstractmethod\n",
        "from datetime import datetime\n",
        "import time\n",
        "\n",
        "class Verktøy(ABC):\n",
        "    \"\"\"Abstrakt baseklasse for verktøy som agenten kan bruke.\"\"\"\n",
        "    \n",
        "    @property\n",
        "    @abstractmethod\n",
        "    def navn(self) -> str:\n",
        "        pass\n",
        "    \n",
        "    @property\n",
        "    @abstractmethod\n",
        "    def beskrivelse(self) -> str:\n",
        "        pass\n",
        "    \n",
        "    @abstractmethod\n",
        "    def kjør(self, **kwargs) -> Dict:\n",
        "        pass\n",
        "\n",
        "class PACSVerktøy(Verktøy):\n",
        "    \"\"\"Verktøy for å hente bilder fra PACS-systemet.\"\"\"\n",
        "    \n",
        "    @property\n",
        "    def navn(self) -> str:\n",
        "        return \"hent_mri_fra_pacs\"\n",
        "    \n",
        "    @property\n",
        "    def beskrivelse(self) -> str:\n",
        "        return \"Henter MRI-bilder fra sykehuset PACS-system basert på pasient-ID\"\n",
        "    \n",
        "    def kjør(self, pasient_id: str) -> Dict:\n",
        "        # Simulerer API-kall til PACS\n",
        "        print(f\"    🔧 Kobler til PACS-server...\")\n",
        "        time.sleep(0.3)\n",
        "        print(f\"    📥 Henter MRI for pasient {pasient_id}...\")\n",
        "        return {\n",
        "            \"status\": \"suksess\",\n",
        "            \"modaliteter\": [\"T1\", \"T1Gd\", \"T2\", \"FLAIR\"],\n",
        "            \"antall_serier\": 4,\n",
        "            \"dato\": \"2024-01-15\"\n",
        "        }\n",
        "\n",
        "class LitteratursøkVerktøy(Verktøy):\n",
        "    \"\"\"Verktøy for å søke i medisinsk litteratur.\"\"\"\n",
        "    \n",
        "    @property\n",
        "    def navn(self) -> str:\n",
        "        return \"søk_pubmed\"\n",
        "    \n",
        "    @property\n",
        "    def beskrivelse(self) -> str:\n",
        "        return \"Søker i PubMed etter relevante artikler basert på tumortype og markører\"\n",
        "    \n",
        "    def kjør(self, tumor_type: str, markører: List[str]) -> Dict:\n",
        "        print(f\"    🔧 Søker PubMed for '{tumor_type}'...\")\n",
        "        time.sleep(0.3)\n",
        "        # Simulerte resultater\n",
        "        return {\n",
        "            \"status\": \"suksess\",\n",
        "            \"antall_treff\": 127,\n",
        "            \"topp_artikler\": [\n",
        "                {\"tittel\": \"IDH mutations in gliomas: NEJM 2023\", \"relevans\": 0.95},\n",
        "                {\"tittel\": \"MGMT methylation as predictor: Lancet Oncol 2024\", \"relevans\": 0.91},\n",
        "                {\"tittel\": \"Novel treatment strategies: JCO 2024\", \"relevans\": 0.88}\n",
        "            ]\n",
        "        }\n",
        "\n",
        "class BiobankVerktøy(Verktøy):\n",
        "    \"\"\"Verktøy for å finne lignende pasienter i biobank.\"\"\"\n",
        "    \n",
        "    @property\n",
        "    def navn(self) -> str:\n",
        "        return \"søk_biobank\"\n",
        "    \n",
        "    @property\n",
        "    def beskrivelse(self) -> str:\n",
        "        return \"Finner lignende pasienter i biobanken basert på molekylær profil\"\n",
        "    \n",
        "    def kjør(self, molekylær_profil: Dict) -> Dict:\n",
        "        print(f\"    🔧 Søker i biobank etter lignende profiler...\")\n",
        "        time.sleep(0.3)\n",
        "        return {\n",
        "            \"status\": \"suksess\",\n",
        "            \"lignende_pasienter\": 23,\n",
        "            \"median_overlevelse\": 18.5,\n",
        "            \"behandlingsrespons\": {\n",
        "                \"temozolomid\": 0.72,\n",
        "                \"stråling\": 0.85\n",
        "            }\n",
        "        }\n",
        "\n",
        "class AgentMinne:\n",
        "    \"\"\"Lagrer agentens handlingshistorikk og observasjoner.\"\"\"\n",
        "    \n",
        "    def __init__(self):\n",
        "        self.handlinger: List[Dict] = []\n",
        "        self.observasjoner: List[str] = []\n",
        "        self.refleksjoner: List[str] = []\n",
        "    \n",
        "    def logg_handling(self, handling: str, resultat: Dict):\n",
        "        self.handlinger.append({\n",
        "            \"tidspunkt\": datetime.now().isoformat(),\n",
        "            \"handling\": handling,\n",
        "            \"resultat\": resultat\n",
        "        })\n",
        "    \n",
        "    def logg_observasjon(self, observasjon: str):\n",
        "        self.observasjoner.append(observasjon)\n",
        "    \n",
        "    def logg_refleksjon(self, refleksjon: str):\n",
        "        self.refleksjoner.append(refleksjon)\n",
        "\n",
        "class GliomAgent:\n",
        "    \"\"\"\n",
        "    Agentisk AI-system for gliom-analyse.\n",
        "    \n",
        "    Kombinerer:\n",
        "    - Nevrosymbolsk resonnering (fra tidligere)\n",
        "    - Verktøybruk (PACS, PubMed, biobank)\n",
        "    - Planlegging og refleksjon\n",
        "    - Human-in-the-loop ved usikkerhet\n",
        "    \"\"\"\n",
        "    \n",
        "    def __init__(self, ns_system: NevrosymbolskGliomSystem):\n",
        "        self.ns_system = ns_system\n",
        "        self.verktøy = {\n",
        "            \"pacs\": PACSVerktøy(),\n",
        "            \"pubmed\": LitteratursøkVerktøy(),\n",
        "            \"biobank\": BiobankVerktøy()\n",
        "        }\n",
        "        self.minne = AgentMinne()\n",
        "        self.usikkerhetsterskel = 0.7\n",
        "    \n",
        "    def planlegg(self, mål: str) -> List[str]:\n",
        "        \"\"\"Planlegger handlinger for å oppnå målet.\"\"\"\n",
        "        print(\"\\n📋 PLANLEGGING\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        plan = [\n",
        "            \"1. Hent MRI-bilder fra PACS\",\n",
        "            \"2. Kjør nevrosymbolsk analyse\",\n",
        "            \"3. Søk etter lignende case i biobank\",\n",
        "            \"4. Finn relevant litteratur\",\n",
        "            \"5. Evaluer konsistens\",\n",
        "            \"6. Generer anbefaling (eller eskalér til kliniker)\"\n",
        "        ]\n",
        "        \n",
        "        print(f\"  Mål: {mål}\")\n",
        "        print(f\"  Plan:\")\n",
        "        for steg in plan:\n",
        "            print(f\"    {steg}\")\n",
        "        \n",
        "        return plan\n",
        "    \n",
        "    def utfør_plan(self, pasient: GliomPasient) -> Dict:\n",
        "        \"\"\"Utfører planen steg for steg med refleksjon.\"\"\"\n",
        "        \n",
        "        mål = f\"Gi optimal behandlingsanbefaling for pasient {pasient.pasient_id}\"\n",
        "        plan = self.planlegg(mål)\n",
        "        \n",
        "        resultater = {}\n",
        "        \n",
        "        # Steg 1: Hent MRI\n",
        "        print(\"\\n🔄 STEG 1: Henter MRI fra PACS\")\n",
        "        print(\"-\" * 40)\n",
        "        pacs_resultat = self.verktøy[\"pacs\"].kjør(pasient_id=pasient.pasient_id)\n",
        "        resultater[\"pacs\"] = pacs_resultat\n",
        "        self.minne.logg_handling(\"hent_mri\", pacs_resultat)\n",
        "        print(f\"    ✓ Mottok {pacs_resultat['antall_serier']} MRI-serier\")\n",
        "        \n",
        "        # Steg 2: Nevrosymbolsk analyse\n",
        "        print(\"\\n🔄 STEG 2: Kjører nevrosymbolsk analyse\")\n",
        "        print(\"-\" * 40)\n",
        "        ns_resultat = self.ns_system.analyser_pasient(pasient)\n",
        "        resultater[\"nevrosymbolsk\"] = ns_resultat\n",
        "        self.minne.logg_handling(\"nevrosymbolsk_analyse\", {\"tumor_type\": ns_resultat[\"symbolsk_klassifikasjon\"][\"tumor_type\"]})\n",
        "        \n",
        "        # Steg 3: Biobank-søk\n",
        "        print(\"\\n🔄 STEG 3: Søker i biobank\")\n",
        "        print(\"-\" * 40)\n",
        "        biobank_resultat = self.verktøy[\"biobank\"].kjør(\n",
        "            molekylær_profil={\"idh\": pasient.molekylær.idh_status.value}\n",
        "        )\n",
        "        resultater[\"biobank\"] = biobank_resultat\n",
        "        self.minne.logg_handling(\"biobank_søk\", biobank_resultat)\n",
        "        print(f\"    ✓ Fant {biobank_resultat['lignende_pasienter']} lignende pasienter\")\n",
        "        \n",
        "        # Steg 4: Litteratursøk\n",
        "        print(\"\\n🔄 STEG 4: Søker i medisinsk litteratur\")\n",
        "        print(\"-\" * 40)\n",
        "        tumor_type = ns_resultat[\"symbolsk_klassifikasjon\"][\"tumor_type\"]\n",
        "        pubmed_resultat = self.verktøy[\"pubmed\"].kjør(\n",
        "            tumor_type=tumor_type,\n",
        "            markører=[pasient.molekylær.idh_status.value]\n",
        "        )\n",
        "        resultater[\"pubmed\"] = pubmed_resultat\n",
        "        self.minne.logg_handling(\"litteratursøk\", pubmed_resultat)\n",
        "        print(f\"    ✓ Fant {pubmed_resultat['antall_treff']} relevante artikler\")\n",
        "        \n",
        "        # Steg 5: Refleksjon\n",
        "        print(\"\\n🤔 STEG 5: Agentens refleksjon\")\n",
        "        print(\"-\" * 40)\n",
        "        refleksjon = self.reflekter(resultater)\n",
        "        resultater[\"refleksjon\"] = refleksjon\n",
        "        \n",
        "        # Steg 6: Beslutning\n",
        "        print(\"\\n📊 STEG 6: Endelig anbefaling\")\n",
        "        print(\"-\" * 40)\n",
        "        \n",
        "        if refleksjon[\"trenger_human_review\"]:\n",
        "            print(\"  ⚠️  ESKALERER TIL KLINIKER\")\n",
        "            print(f\"      Grunn: {refleksjon['eskaleringsgrunn']}\")\n",
        "            print(\"      → Anbefaler MDT-diskusjon før behandlingsstart\")\n",
        "        else:\n",
        "            print(\"  ✓ Anbefaling klar for klinisk vurdering\")\n",
        "            for beh in ns_resultat[\"behandlingsanbefaling\"][\"primær_behandling\"]:\n",
        "                print(f\"      • {beh}\")\n",
        "        \n",
        "        return resultater\n",
        "    \n",
        "    def reflekter(self, resultater: Dict) -> Dict:\n",
        "        \"\"\"\n",
        "        Agenten reflekterer over sine funn og vurderer usikkerhet.\n",
        "        Dette er et kjerneaspekt ved agentisk AI.\n",
        "        \"\"\"\n",
        "        refleksjon = {\n",
        "            \"observasjoner\": [],\n",
        "            \"usikkerhetsvurdering\": \"\",\n",
        "            \"trenger_human_review\": False,\n",
        "            \"eskaleringsgrunn\": None\n",
        "        }\n",
        "        \n",
        "        # Sjekk konsistens i nevrosymbolsk analyse\n",
        "        ns_res = resultater.get(\"nevrosymbolsk\", {})\n",
        "        if not ns_res.get(\"hybrid_validering\", {}).get(\"konsistent\", True):\n",
        "            refleksjon[\"observasjoner\"].append(\n",
        "                \"Inkonsistens mellom nevrale prediksjoner og symbolsk klassifikasjon\"\n",
        "            )\n",
        "            refleksjon[\"trenger_human_review\"] = True\n",
        "            refleksjon[\"eskaleringsgrunn\"] = \"Inkonsistens i analyse - krever manuell verifisering\"\n",
        "        \n",
        "        # Sjekk om biobank-data støtter anbefalingen\n",
        "        biobank_res = resultater.get(\"biobank\", {})\n",
        "        if biobank_res.get(\"lignende_pasienter\", 0) < 10:\n",
        "            refleksjon[\"observasjoner\"].append(\n",
        "                \"Få lignende pasienter i biobank - begrenset evidensgrunnlag\"\n",
        "            )\n",
        "        \n",
        "        # Sjekk litteraturstøtte\n",
        "        pubmed_res = resultater.get(\"pubmed\", {})\n",
        "        if pubmed_res.get(\"topp_artikler\"):\n",
        "            høyeste_relevans = pubmed_res[\"topp_artikler\"][0].get(\"relevans\", 0)\n",
        "            if høyeste_relevans < 0.8:\n",
        "                refleksjon[\"observasjoner\"].append(\n",
        "                    \"Begrenset direkte litteraturstøtte for denne profilen\"\n",
        "                )\n",
        "        \n",
        "        # Oppsummer\n",
        "        if refleksjon[\"trenger_human_review\"]:\n",
        "            refleksjon[\"usikkerhetsvurdering\"] = \"HØY - krever klinisk vurdering\"\n",
        "            print(f\"  ⚠️  Usikkerhet: {refleksjon['usikkerhetsvurdering']}\")\n",
        "        else:\n",
        "            refleksjon[\"usikkerhetsvurdering\"] = \"MODERAT - anbefaling kan presenteres\"\n",
        "            print(f\"  ✓ Usikkerhet: {refleksjon['usikkerhetsvurdering']}\")\n",
        "        \n",
        "        for obs in refleksjon[\"observasjoner\"]:\n",
        "            print(f\"  → Observasjon: {obs}\")\n",
        "            self.minne.logg_observasjon(obs)\n",
        "        \n",
        "        self.minne.logg_refleksjon(refleksjon[\"usikkerhetsvurdering\"])\n",
        "        \n",
        "        return refleksjon\n",
        "\n",
        "print(\"✓ Agentisk AI-rammeverk definert\")\n",
        "print(\"  - Verktøy: PACS, PubMed, Biobank\")\n",
        "print(\"  - Kapabiliteter: Planlegging, Refleksjon, Human-in-the-loop\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "======================================================================\n",
            "AGENTISK GLIOM-ANALYSE: Fullstendig arbeidsflyt\n",
            "======================================================================\n",
            "\n",
            "🤖 Starter agentisk analyse av Pasient C (ASTRO-117)\n",
            "   Denne pasienten har potensielle inkonsistenser som agenten må håndtere\n",
            "\n",
            "\n",
            "📋 PLANLEGGING\n",
            "----------------------------------------\n",
            "  Mål: Gi optimal behandlingsanbefaling for pasient ASTRO-117\n",
            "  Plan:\n",
            "    1. Hent MRI-bilder fra PACS\n",
            "    2. Kjør nevrosymbolsk analyse\n",
            "    3. Søk etter lignende case i biobank\n",
            "    4. Finn relevant litteratur\n",
            "    5. Evaluer konsistens\n",
            "    6. Generer anbefaling (eller eskalér til kliniker)\n",
            "\n",
            "🔄 STEG 1: Henter MRI fra PACS\n",
            "----------------------------------------\n",
            "    🔧 Kobler til PACS-server...\n",
            "    📥 Henter MRI for pasient ASTRO-117...\n",
            "    ✓ Mottok 4 MRI-serier\n",
            "\n",
            "🔄 STEG 2: Kjører nevrosymbolsk analyse\n",
            "----------------------------------------\n",
            "\n",
            "============================================================\n",
            "NEVROSYMBOLSK ANALYSE: Pasient ASTRO-117\n",
            "============================================================\n",
            "\n",
            "[STEG 1] NEVRAL KOMPONENT: MRI-analyse\n",
            "----------------------------------------\n",
            "  Tumorvolum: 48.7 ml\n",
            "  Enhancing: 18.3 ml (37.6%)\n",
            "  Nekrose: 6.2 ml\n",
            "  Ødem: 35.1 ml\n",
            "  Lokalisasjon: parietal\n",
            "\n",
            "  Radiogenomikk-prediksjoner:\n",
            "    IDH-villtype: 82% (usikkerhet: moderat)\n",
            "    MGMT-metylert: 40% (usikkerhet: høy)\n",
            "\n",
            "[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\n",
            "----------------------------------------\n",
            "  Anvendte regler:\n",
            "    → IDH-mutasjon påvist\n",
            "    → Ingen 1p/19q ko-delesjon → Astrocytom\n",
            "    → ATRX-tap bekrefter astrocytom-linje\n",
            "  Konklusjon: Astrocytom, IDH-mutert, grad 4\n",
            "\n",
            "[STEG 3] HYBRID VALIDERING: Konsistenssjekk\n",
            "----------------------------------------\n",
            "  ⚠ INKONSISTENS oppdaget:\n",
            "    → Nevral modell predikerer IDH-villtype (82%), men faktisk status er IDH-mutert\n",
            "\n",
            "[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\n",
            "----------------------------------------\n",
            "  Primær behandling:\n",
            "  Prognostiske kommentarer:\n",
            "    → MGMT-metylert: Forventet bedre respons på temozolomid\n",
            "\n",
            "[STEG 5] FORKLARING FOR KLINIKER\n",
            "----------------------------------------\n",
            "\n",
            "SAMMENDRAG FOR PASIENT ASTRO-117:\n",
            "\n",
            "DIAGNOSE: Astrocytom, IDH-mutert, grad 4\n",
            "  - WHO-grad: GRAD_4\n",
            "  - Median overlevelse: 36 måneder\n",
            "\n",
            "MOLEKYLÆR PROFIL:\n",
            "  - IDH-status: IDH-mutert\n",
            "  - MGMT-status: MGMT-metylert\n",
            "  - 1p/19q ko-delesjon: Nei\n",
            "\n",
            "KLINISK:\n",
            "  - Alder: 51 år\n",
            "  - Karnofsky: 80\n",
            "\n",
            "VALIDERING: Se advarsler ovenfor\n",
            "\n",
            "\n",
            "🔄 STEG 3: Søker i biobank\n",
            "----------------------------------------\n",
            "    🔧 Søker i biobank etter lignende profiler...\n",
            "    ✓ Fant 23 lignende pasienter\n",
            "\n",
            "🔄 STEG 4: Søker i medisinsk litteratur\n",
            "----------------------------------------\n",
            "    🔧 Søker PubMed for 'astrocytom_4'...\n",
            "    ✓ Fant 127 relevante artikler\n",
            "\n",
            "🤔 STEG 5: Agentens refleksjon\n",
            "----------------------------------------\n",
            "  ⚠️  Usikkerhet: HØY - krever klinisk vurdering\n",
            "  → Observasjon: Inkonsistens mellom nevrale prediksjoner og symbolsk klassifikasjon\n",
            "\n",
            "📊 STEG 6: Endelig anbefaling\n",
            "----------------------------------------\n",
            "  ⚠️  ESKALERER TIL KLINIKER\n",
            "      Grunn: Inkonsistens i analyse - krever manuell verifisering\n",
            "      → Anbefaler MDT-diskusjon før behandlingsstart\n",
            "\n",
            "======================================================================\n",
            "AGENTENS MINNE (handlingslogg)\n",
            "======================================================================\n",
            "\n",
            "Antall handlinger utført: 4\n",
            "Antall observasjoner: 1\n",
            "Refleksjoner: ['HØY - krever klinisk vurdering']\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DEMONSTRASJON: Agentisk analyse av gliom-pasient\n",
        "# ============================================================================\n",
        "\n",
        "print(\"=\" * 70)\n",
        "print(\"AGENTISK GLIOM-ANALYSE: Fullstendig arbeidsflyt\")\n",
        "print(\"=\" * 70)\n",
        "\n",
        "# Opprett agenten\n",
        "agent = GliomAgent(ns_system)\n",
        "\n",
        "# Kjør agent på pasient C (den med inkonsistens - interessant for agenten!)\n",
        "print(\"\\n🤖 Starter agentisk analyse av Pasient C (ASTRO-117)\")\n",
        "print(\"   Denne pasienten har potensielle inkonsistenser som agenten må håndtere\\n\")\n",
        "\n",
        "agent_resultater = agent.utfør_plan(pasient_c)\n",
        "\n",
        "# Vis agentens minne\n",
        "print(\"\\n\" + \"=\" * 70)\n",
        "print(\"AGENTENS MINNE (handlingslogg)\")\n",
        "print(\"=\" * 70)\n",
        "print(f\"\\nAntall handlinger utført: {len(agent.minne.handlinger)}\")\n",
        "print(f\"Antall observasjoner: {len(agent.minne.observasjoner)}\")\n",
        "print(f\"Refleksjoner: {agent.minne.refleksjoner}\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "### Oppsummering: Agentisk AI i medisin\n",
        "\n",
        "#### Fordeler med agentisk tilnærming\n",
        "\n",
        "| Aspekt | Tradisjonell AI | Agentisk AI |\n",
        "|--------|-----------------|-------------|\n",
        "| **Arbeidsflyt** | Enkelt modellkall | Orkestrerer flere steg |\n",
        "| **Verktøy** | Ingen | Integrerer med PACS, EPJ, databaser |\n",
        "| **Usikkerhet** | Passiv rapportering | Aktiv eskalering til kliniker |\n",
        "| **Kontekst** | Stateless | Minne over tid |\n",
        "| **Tilpasning** | Fast pipeline | Dynamisk planlegging |\n",
        "\n",
        "#### Klinisk relevans\n",
        "\n",
        "1. **Redusert kognitiv belastning**: Agenten håndterer rutineoppgaver\n",
        "2. **Kvalitetssikring**: Automatisk konsistenssjekk og litteraturstøtte\n",
        "3. **Dokumentasjon**: Full sporbarhet av beslutningsgrunnlag\n",
        "4. **Skalerbarhet**: Kan håndtere mange pasienter parallelt\n",
        "\n",
        "#### Utfordringer og etikk\n",
        "\n",
        "- **Ansvar**: Hvem er ansvarlig når agenten tar feil?\n",
        "- **Transparens**: Må kunne forklare alle handlinger\n",
        "- **Kontroll**: Human-in-the-loop er essensielt\n",
        "- **Sikkerhet**: Må ikke utføre skadelige handlinger\n",
        "\n",
        "#### Fremtidsvisjon: LLM-baserte medisinske agenter\n",
        "\n",
        "Med fremveksten av store språkmodeller (LLM) kan medisinske agenter:\n",
        "- Forstå naturlig språk fra klinikere\n",
        "- Resonnere over komplekse medisinske case\n",
        "- Generere strukturerte rapporter\n",
        "- Lære fra feedback over tid\n",
        "\n",
        "> **Viktig**: Agentisk AI i medisin må alltid operere under menneskelig tilsyn, \n",
        "> spesielt for kritiske beslutninger som behandlingsvalg."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 29,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "============================================================\n",
            "GENERERER TILFELDIG PASIENT FOR UTFORSKNING\n",
            "============================================================\n",
            "\n",
            "Tips: Kjør denne cellen flere ganger for å se ulike case!\n",
            "Endre 'seed' parameter for reproduserbare resultater.\n",
            "\n",
            "\n",
            "============================================================\n",
            "NEVROSYMBOLSK ANALYSE: Pasient RANDOM-2532\n",
            "============================================================\n",
            "\n",
            "[STEG 1] NEVRAL KOMPONENT: MRI-analyse\n",
            "----------------------------------------\n",
            "  Tumorvolum: 18.7 ml\n",
            "  Enhancing: 1.9 ml (10.2%)\n",
            "  Nekrose: 0 ml\n",
            "  Ødem: 6.1 ml\n",
            "  Lokalisasjon: occipital\n",
            "\n",
            "  Radiogenomikk-prediksjoner:\n",
            "    IDH-villtype: 34% (usikkerhet: moderat)\n",
            "    MGMT-metylert: 31% (usikkerhet: høy)\n",
            "\n",
            "[STEG 2] SYMBOLSK KOMPONENT: WHO-klassifikasjon\n",
            "----------------------------------------\n",
            "  Anvendte regler:\n",
            "    → IDH-mutasjon påvist\n",
            "    → 1p/19q ko-delesjon påvist → Oligodendrogliom\n",
            "  Konklusjon: Oligodendrogliom, grad 2\n",
            "\n",
            "[STEG 3] HYBRID VALIDERING: Konsistenssjekk\n",
            "----------------------------------------\n",
            "  ✓ Nevrale prediksjoner er KONSISTENTE med symbolsk klassifikasjon\n",
            "\n",
            "[STEG 4] BEHANDLINGSANBEFALING: Regelbasert\n",
            "----------------------------------------\n",
            "  Primær behandling:\n",
            "\n",
            "[STEG 5] FORKLARING FOR KLINIKER\n",
            "----------------------------------------\n",
            "\n",
            "SAMMENDRAG FOR PASIENT RANDOM-2532:\n",
            "\n",
            "DIAGNOSE: Oligodendrogliom, IDH-mutert, 1p/19q ko-deletert, grad 2\n",
            "  - WHO-grad: GRAD_2\n",
            "  - Median overlevelse: 156 måneder\n",
            "\n",
            "MOLEKYLÆR PROFIL:\n",
            "  - IDH-status: IDH-mutert\n",
            "  - MGMT-status: MGMT-umetylert\n",
            "  - 1p/19q ko-delesjon: Ja\n",
            "\n",
            "KLINISK:\n",
            "  - Alder: 35 år\n",
            "  - Karnofsky: 80\n",
            "\n",
            "VALIDERING: Konsistent\n",
            "\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# INTERAKTIV UTFORSKNING: Lag din egen pasient\n",
        "# ============================================================================\n",
        "\n",
        "def lag_tilfeldig_pasient(seed: int = None) -> GliomPasient:\n",
        "    \"\"\"\n",
        "    Genererer en tilfeldig gliom-pasient for utforskning.\n",
        "    Prøv å endre parametrene og se hvordan klassifikasjonen endres!\n",
        "    \"\"\"\n",
        "    if seed is not None:\n",
        "        np.random.seed(seed)\n",
        "    \n",
        "    # Tilfeldig molekylær profil\n",
        "    idh = np.random.choice([IDHStatus.VILLTYPE, IDHStatus.MUTERT], p=[0.4, 0.6])\n",
        "    mgmt = np.random.choice([MGMTStatus.METYLERT, MGMTStatus.UMETYLERT], p=[0.45, 0.55])\n",
        "    \n",
        "    # Hvis IDH-mutert, bestem subtype\n",
        "    if idh == IDHStatus.MUTERT:\n",
        "        er_oligo = np.random.choice([True, False], p=[0.35, 0.65])\n",
        "    else:\n",
        "        er_oligo = False\n",
        "    \n",
        "    molekylær = MolekylærProfil(\n",
        "        idh_status=idh,\n",
        "        mgmt_status=mgmt,\n",
        "        kodeletion_1p19q=er_oligo,\n",
        "        atrx_tap=not er_oligo and idh == IDHStatus.MUTERT,\n",
        "        tert_promoter=idh == IDHStatus.VILLTYPE and np.random.random() > 0.3,\n",
        "        egfr_amplifisering=idh == IDHStatus.VILLTYPE and np.random.random() > 0.6\n",
        "    )\n",
        "    \n",
        "    # Tilfeldig MRI\n",
        "    tumor_vol = np.random.uniform(15, 100)\n",
        "    mri = MRIFeatures(\n",
        "        tumor_volum_ml=round(tumor_vol, 1),\n",
        "        enhancing_volum_ml=round(np.random.uniform(0, tumor_vol * 0.5), 1),\n",
        "        nekrose_volum_ml=round(np.random.uniform(0, tumor_vol * 0.2), 1) if idh == IDHStatus.VILLTYPE else 0,\n",
        "        ødem_volum_ml=round(np.random.uniform(5, tumor_vol * 0.8), 1),\n",
        "        lokalisasjon=np.random.choice([\"frontal\", \"temporal\", \"parietal\", \"occipital\"])\n",
        "    )\n",
        "    \n",
        "    # Tilfeldig klinisk profil\n",
        "    klinisk = KliniskProfil(\n",
        "        alder=np.random.randint(25, 80),\n",
        "        karnofsky_score=np.random.choice([60, 70, 80, 90, 100]),\n",
        "        symptom_varighet_uker=np.random.randint(2, 24)\n",
        "    )\n",
        "    \n",
        "    return GliomPasient(\n",
        "        pasient_id=f\"RANDOM-{np.random.randint(1000, 9999)}\",\n",
        "        molekylær=molekylær,\n",
        "        mri=mri,\n",
        "        klinisk=klinisk\n",
        "    )\n",
        "\n",
        "# Generer og analyser en tilfeldig pasient\n",
        "print(\"=\" * 60)\n",
        "print(\"GENERERER TILFELDIG PASIENT FOR UTFORSKNING\")\n",
        "print(\"=\" * 60)\n",
        "print(\"\\nTips: Kjør denne cellen flere ganger for å se ulike case!\")\n",
        "print(\"Endre 'seed' parameter for reproduserbare resultater.\\n\")\n",
        "\n",
        "tilfeldig_pasient = lag_tilfeldig_pasient(seed=2024)\n",
        "resultat_tilfeldig = ns_system.analyser_pasient(tilfeldig_pasient)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## 7. Fremtidsperspektiver\n",
        "\n",
        "### Hvorfor nevrosymbolsk AI er viktig for medisin\n",
        "\n",
        "1. **Forklarbarhet**: Symbolsk kunnskap gir meningsfulle forklaringer\n",
        "2. **Robusthet**: Ontologier fanger opp feil og inkonsistenser\n",
        "3. **Datamangel**: Kan utnytte eksisterende medisinsk kunnskap\n",
        "4. **Regulering**: Lettere å verifisere og godkjenne\n",
        "5. **Tillit**: Leger forstår resonnementet\n",
        "\n",
        "### Aktive forskningsområder\n",
        "\n",
        "- Knowledge-enhanced LLMs (f.eks. kobling av GPT til SNOMED)\n",
        "- Neural-symbolic reasoning i biomedisinske grafer\n",
        "- Ontology learning fra ustrukturert tekst\n",
        "- Forklaring av dype modeller via symbolsk mapping"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "\n",
        "## Oppsummering\n",
        "\n",
        "### Hovedpunkter\n",
        "\n",
        "1. **To AI-tradisjoner**: Symbolsk (tolkbar, regelbasert) vs. nevral (lærer fra data)\n",
        "2. **Nevrosymbolsk AI** kombinerer styrkene til begge tilnærminger\n",
        "3. **Kunnskapsgrafer** representerer medisinsk kunnskap som nettverk av entiteter og relasjoner\n",
        "4. **Ontologier** (SNOMED, ICD, WHO CNS-klassifikasjon) gir standardisert vokabular\n",
        "5. **Hybrid systemer** gir bedre forklarbarhet, robusthet og konsistenssjekking\n",
        "6. **Gliom-casestudien** demonstrerer praktisk nevrosymbolsk AI i nevro-onkologi:\n",
        "   - Nevral komponent: MRI-segmentering og radiogenomikk\n",
        "   - Symbolsk komponent: WHO 2021-klassifikasjon og behandlingsregler\n",
        "   - Hybrid validering: Automatisk oppdagelse av inkonsistenser\n",
        "7. **Agentisk AI** utvider nevrosymbolsk AI med:\n",
        "   - Autonom planlegging og handling\n",
        "   - Verktøybruk (PACS, databaser, litteratursøk)\n",
        "   - Refleksjon og human-in-the-loop ved usikkerhet\n",
        "   - Minne og kontekstuell forståelse over tid\n",
        "\n",
        "### Refleksjonsoppgaver\n",
        "\n",
        "1. **Kunnskapsgrafer**: Hvordan kunne en kunnskapsgraf forbedret et AI-system du kjenner til?\n",
        "\n",
        "2. **Medisinske domener**: Hvilke andre medisinske domener (utover nevro-onkologi) tror du har mest nytte av nevrosymbolsk AI? Tenk på områder med:\n",
        "   - Rik domenekunskap (ontologier, retningslinjer)\n",
        "   - Behov for forklarbarhet\n",
        "   - Kritiske beslutninger\n",
        "\n",
        "3. **Gliom-casen**: I gliom-casestudien så vi at systemet kunne oppdage inkonsistenser mellom MRI-features og molekylær profil. Hvorfor er dette viktig klinisk?\n",
        "\n",
        "4. **Regulering**: Hvordan kan nevrosymbolsk AI gjøre det enklere å få godkjent medisinsk AI-programvare (f.eks. som medisinsk utstyr)?\n",
        "\n",
        "5. **Utfordringer**: Hva ser du som de største utfordringene med å implementere nevrosymbolsk AI i klinisk praksis?\n",
        "\n",
        "6. **Agentisk AI**: I demonstrasjonen så vi hvordan en AI-agent kunne orkestrere hele arbeidsflyten fra MRI til behandlingsanbefaling. Hvilke fordeler og risikoer ser du med slike autonome systemer i helsevesenet? Når bør agenten alltid eskalere til en kliniker?\n",
        "\n",
        "---\n",
        "\n",
        "### Videre lesning\n",
        "\n",
        "- [Neuro-Symbolic AI: The 3rd Wave](https://arxiv.org/abs/2012.05876) - Garcez & Lamb (2020)\n",
        "- [WHO Classification of Tumours of the CNS, 5th Edition (2021)](https://tumourclassification.iarc.who.int/)\n",
        "- [BraTS Challenge](https://www.synapse.org/brats) - Brain Tumor Segmentation\n",
        "- [Knowledge Graphs in Healthcare](https://doi.org/10.1016/j.jbi.2020.103602) - Nicholson & Greene (2020)\n",
        "\n",
        "---\n",
        "\n",
        "*Neste notebook: [09 - ChatGPT/Claude API](09-chatgpt-claude-api.ipynb)*"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": []
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "elmed219-2026",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.10.19"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 4
}
